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 Abstract 
The blood-cerebrospinal fluid-barrier, including choroid plexus epithelial cells (CPEC), is the 
major site of homeostatic leukocyte trafficking into the CNS; however it is unknown whether 
CPEC can alter T cell function or recruit T cells as suggested by the dominance of central 
memory T cells in the CSF. This study therefore investigated; (1) whether CPEC inhibit CD4
+ 
T cell proliferation, and (2) if CPEC can influence CD4
+ 
T cell migration.  
Using human amniotic epithelial cells (AEC) as a comparison, human CPEC or conditioned 
medium from the cells were incubated with CD4
+ 
T cells and proliferation assessed after 96 
hours. The migration of CD4
+ 
T cell subsets through CPEC or AEC grown in inverted culture, 
to mimic physiologically relevant basolateral-apical migration, was also assessed.   
Conditioned medium inhibited CD4
+ 
T cell proliferation by 67% (CPEC) and 65% (AEC), 
whereas direct contact inhibited proliferation by 90% (CPEC) and 71% (AEC). Inverted co-
culture mediated a 20% (CPEC) and 26% (AEC) increase in central memory CD4
+ 
T cell 
migration.   
Results demonstrate a strong immunosuppressive role for both CPEC and AEC. Both cell 
types preferentially recruit central memory CD4
+ 
T cells suggesting that cells from immune 
privileged sites may universally employ this mechanism of immune surveillance. 
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Introduction 
1.1 Properties of blood-CNS barriers 
The central nervous system (CNS) has long been considered an immunologically privileged 
site owing to a number of unique anatomical features. Non-haematopoietic cells in the CNS 
lack MHC class I and class II expression, there is no distinctive lymphatic drainage system 
(thus no antigenic interactions), and physical and chemical protection is provided by 
endothelial barriers (Abbott et al., 2009). Over the years the theory of CNS immune privilege 
has been extensively challenged and as increasing evidence of the requirement of immune 
cells in the CNS emerges, such as in bacterial or parasitic infections in the brain, it has been 
suggested that the CNS could more appropriately be termed an ‘immunologically specialised 
site’ (Ransohoff et al., 2003).  
The concept of biological barriers between the blood and CNS was established nearly 130 
years ago in a seminal study by Paul Ehrlich; a finding later confirmed by Ehrlich’s associate 
Edwin Goldmann who discovered that a water-soluble dye infused into the circulation was 
unable to stain brain tissue, but that the same dye infused into the cerebrospinal fluid (CSF) 
was able to stain brain tissue (Wolburg et al., 2010). Though distinctly different, the blood-
CNS barriers possess universal properties vital to the maintenance of CNS integrity including 
tight junctions, providing a physical barrier in which only permitted cells and molecules may 
pass, and channels regulating the transport of solutes in and out of the CNS (Abbott., 2003).  
 
1.2 Leukocyte Trafficking in the CNS 
There is limited entry of leukocytes into the CNS; however three main entry sites have been 
distinguished. The blood-brain-barrier (BBB), composed of tightly packed endothelial cells 
forming CNS microvessels, is the largest site for blood-CNS exchange and covers a total 
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surface area of between 12 and 18m
2
 in an average human adult (Abbott  et al., 2009). 
Enclosing the CNS are arachnoid cells that constitute the avascular blood-arachnoid-barrier 
(BAB), and the final interface is the blood-cerebrospinal fluid barrier (BCSFB) formed by the 
choroid plexus, lining the cerebral ventricles. This barrier is composed of specialised 
epithelial cells known as choroid plexus epithelial cells (CPEC) that maintain brain 
homeostasis and secrete CSF into the ventricles. Due to the high rate of blood flow required 
for these activities and that the choroid plexus capillaries supplying the blood are fenestrated 
and lack tight junctions, opportunities for lymphocyte migration across the epithelium and 
into the perivascular space are more commonly presented, where contact with the choroid 
plexus can occur (Meeker et al., 2012).  
The sequential process of lymphocyte migration into the CNS under inflammatory conditions 
has been widely studied, particularly in the context of experimental autoimmune 
encephalomyelitis (EAE); the prototype animal model for multiple sclerosis (MS). Activation 
of CD4
+ 
T cells in the periphery against structural CNS auto-antigens leads to recruitment and 
infiltration into the CNS via activated endothelial cells of the BBB, where migration is 
facilitated by reduced tight junction integrity and inflammatory events are maintained 
(Wolburg et al., 2010).  
Conversely, lymphocytes also migrate into the CNS under ‘normal’ homeostatic 
circumstances to patrol the CNS for pathogens. This immune surveillance is distinct from the 
processes mediating lymphocyte migration in inflammation and is thought to occur across the 
BCSFB where selectins and adhesion molecules necessary for T cell migration are 
constitutively expressed, rather than across the BBB, where endothelial cells lack the 
necessary adhesion molecules required by T cells in the absence of inflammation (Goverman 
2009). As the major site of immune cell trafficking between the periphery and the CNS, the 
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BCSFB has been described as a specialised gateway rather than a barrier (Shechter et al., 
2013). 
 
1.3 Molecules Involved in Leukocyte Trafficking 
A range of cytokines, chemokines and adhesion molecules are involved in leukocyte 
trafficking into the CNS. Adhesion molecules constitutively expressed by the choroid plexus 
include P-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion 
molecule-1 (VCAM-1), suggesting their involvement in regulating leukocyte entry (Steffen et 
al., 1996; Kivisakk et al., 2003). Recent evidence has implicated the involvement of the pro-
inflammatory cytokine interferon-γ (IFN-γ) in immune cell trafficking across the BCSFB, 
inducing the upregulation of adhesion molecules (Kunis et al., 2013). In addition, the 
chemokine receptor CXCR3 also plays a role in leukocyte trafficking. CXCR3 is generally 
associated with lymphocyte migration into the CNS during inflammatory conditions but 
previous work has shown it is also involved in immune surveillance, with the majority of T 
cells in the CSF expressing CXCR3 regardless of disease status (Kivisakk et al., 2002). The 
range of molecules involved in leukocyte trafficking may suggest that various combinations 
of these molecules are required to recruit certain cell types to the CNS under different 
conditions.     
 
1.4 Immune Surveillance in the CNS 
The high occurrence of CD4
+ 
central memory T cells in normal CSF (~90% of leukocytes 
compared to ~58% in peripheral blood) implies their involvement in CNS immune 
surveillance and that these cells may be granted entry into the CNS by selective recruitment 
(Wilson et al., 2010; de Graaf et al., 2011). This concept is generally accepted but it could 
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also be suggested that rather than simply acting as gatekeepers, CPEC actively function to 
modulate the phenotype of migrating lymphocytes as they traverse the BCSFB. In any case, 
activated CD4
+ 
T cells in the CNS must be amenable to rapid inhibition in order to prevent the 
damaging consequences of inflammation and maintain immune privilege. Excessive 
activation would override the mechanisms suppressing CD4
+ 
T cell proliferation resulting in 
inflammation and potentially fatal damage, as seen in infections such as meningitis. In other 
words, for CNS inflammation to occur a stimulus strong enough to exceed the threshold of 
CD4
+ 
T cell suppression is required. 
 
1.5 Immunomodulation by Epithelial Cells 
 As CPEC constitute the barrier between blood and CSF and therefore the periphery and the 
CNS, it seems likely that they would provide (or at least contribute to) the ‘switching off’ 
signal required to keep activated CD4
+ 
T cells in check. Other types of epithelial cells, 
including colonic epithelial cells, retinal pigmented epithelial cells and amniotic epithelial 
cells have the ability to mediate localised immune privilege by suppressing the proliferation 
of activated CD4
+ 
T cells via an array of cell-bound and soluble mediators (Cruickshank et 
al., 2004; Gregerson et al., 2007; Qureshi et al., 2010). For example, soluble factors known to 
promote ocular immune privilege by retinal pigmented epithelial cells include α-melanocyte 
stimulating hormone (α-MSH), vasoactive intestinal peptide (VIP), interleukin-1 receptor α 
(IL-1Rα) and thrombospondin, which interact with the immune system through a range of 
mechanisms and could also be linked with immunomodulation mediated by other types of 
epithelial cells (Taylor et al., 1994; Kennedy et al., 1995; Sheibani et al., 1997; Namba et al., 
2002).  
- 5 - 
 
Transforming growth factor-β (TGF-β) is an immunomodulatory molecule secreted by 
epithelial cells which inhibits CD4
+ 
T cell proliferation by inducing cell cycle arrest at the G1 
phase (Howe et al., 1991; Knuckey et al., 1996; Li et al., 2005). Arachidonic acid-derived 
prostaglandin E2 (PGE2) is another immunoregulatory molecule and acts by inhibiting IL-2 
production, thus preventing T cell activation and proliferation. PGE2 can be secreted by all 
cell types with epithelial cells constituting one of the major sources of PGE2 in the body (Liu 
et al., 2012; Kalinski, 2012). 
The induction of anergy, characterised by the inactivation of lymphocytes, is an important 
protective mechanism to prevent self-reactivity and autoimmunity. Two types have been 
described; (1) clonal anergy, arising from incomplete activation and growth arrest in 
previously activated cells, and (2) adaptive tolerance, induced in naïve T cells in an 
environment high in inhibitory molecules (such as Cytotoxic T Lymphocyte Antigen-4 
(CTLA-4)) or low in co-stimulatory molecules required for complete activation (Schwartz, 
2003). Such mechanisms of inhibiting T cell proliferation have been observed in renal tubular 
epithelial cells and thymic medullary epithelial cells and may therefore be a universal 
property of epithelial cells (Hoffmann et al., 1992; Singer et al., 1993).  
As well as soluble molecules, epithelial cells also employ cell-bound factors to modulate the 
immune system. The death receptors Fas Ligand (FasL) and TNF-Related Apoptosis-Inducing 
Ligand (TRAIL) are known to cause Activation-Induced Cell Death (AICD) in T cells, 
possibly by upregulation following Tumour Necrosis Factor-α (TNFα) secretion by activated 
T cells (Green et al., 2003). A hallmark of immune privilege, FasL and TRAIL induce 
caspase-dependent apoptosis and are expressed in numerous locations including the eye, testis 
and intestines (Griffith et al., 1995; Xu et al., 1999; Green et al., 2001).    
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Another receptor known to modulate T cells is programmed death ligand-1 (PD-L1). Also 
known as B7-H1, PD-L1 is a counter-regulatory molecule of T cell stimulation and a member 
of the CD28 family which inhibits T cell proliferation by ligating PD-1 on activated T cells 
(Freeman et al., 2000). PD-L1 is inducibly expressed by a range of cell types including 
colonic epithelial cells, gastric epithelial cells and airway epithelial cells, and is constitutively 
expressed in retinal pigmented epithelial cells (Cruickshank et al., 2004; Beswick et al., 2007; 
Heinecke et al., 2008; Sugita et al., 2009). Since PD-L1 is also expressed at the foetal-
maternal interface, it is thought that this pathway may be important in regulating the immune 
responses at immune privileged sites (Guleria et al., 2005). 
Though strong evidence exists to support the immunoloduatory properties of epithelial cells, 
the difficulties in obtaining human CPEC means that this phenomenon has not been explored 
in these cells thus far.   
 
1.6 Aims and Hypothesis of the Study 
The hypothesis of this study was that CPEC inhibit the proliferation of CD4
+ 
T cells, and 
preferentially recruit central memory CD4
+ 
T cells.  
In this study the interactions of CD4
+ 
T cells and CPEC were investigated, using AEC as a 
comparison, to determine whether CPEC can influence the proliferation and migration of 
CD4
+ 
T cells in vitro. Assays were based on the influence of CPEC in direct contact with 
CD4
+ 
T cells or using conditioned media to investigate the effects of soluble factors, and on 
the influence of CD4
+ 
T cell migration by employing an inverted culture system to mimic 
physiological basolateral to apical migration across the choroid plexus.  
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Methods 
2.1 Human Amniotic Epithelial Cell (AEC) Isolation 
Human AEC were isolated from placentas delivered by elective caesarean section following 
previously published protocols (Qureshi et al., 2010). All procedures were carried out with 
fully informed ethical consent, following Local Research Ethics Committee guidelines.  
 
2.2 Cell culture 
Human CPEC (ScienCell Research Laboratories, Carlsbad, CA) were cultured in the 
recommended culture media EpiCM, supplemented with 10% foetal bovine serum (FBS), 
epithelial cell growth supplement and penicillin-streptomycin solution (ScienCell Research 
Laboratories). Culture surfaces were pre-coated with poly-l-lysine (2µg/cm
2
, ScienCell 
Research Laboratories) to promote cell attachment, as instructed by the manufacturer. 
Medium was changed every 3-4 days and cells were passaged when 70-90% confluent. Cells 
were used at passage 3-6. AEC were cultured in complete RPMI supplemented with 10% 
FBS, 1% L-glutamine-penicillin-streptomycin solution (GPS) and 10ng/ml epidermal growth 
factor (EGF; Sigma Aldrich) with medium changes every 3-4 days. Cells were passaged when 
70-90% confluent and used at passage 2-5. 
 
2.3 Peripheral Blood Mononuclear Cell (PBMC) Isolation 
PBMC were isolated from healthy consenting donors following ethics guidelines under study 
number UKCR4654. Blood was collected in tubes containing 50IU heparin sodium (LEO 
laboratories, Buckinghamshire, UK), diluted 1:1 with serum-free RPMI containing 1% GPS 
and 1% HEPES, layered onto ficoll-paque (GE Healthcare Bio-Sciences, Uppsala, Sweden) 
and centrifuged at 400xg for 30 min with no brake. Leukocyte layers were harvested and 
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washed for 8 min at 300xg, 200xg (to remove platelets) and 300xg in serum-free RPMI and 
re-suspended in 10ml RPMI after the final wash for counting.  
 
2.4 Proliferation Dye Labelling 
PBMC were re-suspended at 2x10
7
/ml and a 20µM solution of violet proliferation dye 
solution (eFluor 450, eBioscience, Hatfield, UK) was mixed 1:1 with cells to give a final dye 
concentration of 10µM. Cells were incubated for 10 min at 37°C in the dark prior to adding 5 
times the volume of cold complete RPMI and incubating on ice for 5 min. Cells were washed 
3 times in complete RPMI at 300xg for 8 min.  
 
2.5 Positive Selection of CD4
+ 
T Cells 
PBMC were kept cold during the following stages and 10µl of the PBMC suspension was 
retained for purity check. Cells were centrifuged at 300xg for 10 min and the supernatant was 
carefully aspirated completely, prior to re-suspending in 80µl MACS buffer (sterile phosphate 
buffered saline (PBS), 0.1% BSA and 2mM EDTA; Sigma Aldrich) per 10
7 
PBMC. 20µl of 
CD4 Microbeads (Miltenyi Biotec, Surrey, UK) were added per 10
7
 cells and the cell 
suspension was incubated for 15 min at 2-4°C. 1-2ml MACS buffer was added per 10
7
 cells 
and the cell suspension was washed at 300xg for 10 min. PBMC were re-suspended in 500µl 
MACS buffer and were passed through a MS column (Miltenyi Biotec) on a pre-washed 
magnetic column separator. The unlabelled CD4
+ 
fraction was collected and the column was 
washed 3 times before removing from the magnetic column separator. 1ml MACS buffer was 
added to the column and the plunger was firmly pushed into the column over a universal tube 
to collect the CD4
+
 cells. From each fraction, 10µl was retained and each (PBMC, CD4
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negative cells and CD4 positive cells) stained with anti-CD4-APC antibody (clone 1/80 
dilution in PBS/2%BSA; Miltenyi Biotec) to assess purity. 
 
2.6 Anti-CD3/anti-CD28 Dynabead Titration 
To determine the optimal number of anti-CD3/anti-CD28-coated stimulatory beads 
(Dynabeads; Life Technologies, Invitrogen, Paisley, UK) required to produce robust and 
reproducible CD4
+ 
T cell activation for the proliferation assays, a titration was carried out. 
Violet proliferation dye-labelled CD4
+
 T cells were incubated with varying Dynabead ratios 
from 1:1 to 1:64 at 2x10
5 
cells/well in a 96 well plate. Cells were incubated for 96 hours and 
proliferation was assessed by flow cytometry.  
 
2.7 Proliferation Assays 
To investigate the influence of CPEC or AEC on proliferation, CD4
+ 
T cells were incubated 
with either conditioned media (CM) or CPEC or AEC directly. 
For CM assays, CM was collected from confluent CPEC or AEC cultured in complete RPMI 
with no EGF for 72-96 hours and centrifuged at 1000xg for 10 min to pellet any debris. CM 
was decanted into new tubes and stored at -20°C until needed. Violet proliferation dye-
labelled CD4
+ 
T cells were incubated in CM from CPEC or AEC, with or without anti-
CD3/anti-CD28 bead stimulation (using a 1:8 cell-to-bead ratio). CM assays were carried out 
in flat-bottomed 96 well plates pre-coated with poly-l-lysine (2µg/cm
2
) prior to adding CPEC 
and AEC at 2.5x10
4
cells/cm
2
 (cell density was determined by titration) and incubating for 72 
hours. Plates were washed in sterile PBS and 1x10
5
 CD4
+ 
T cells were added per well. After a 
96 hour incubation period CD4
+ 
T cells were retrieved, wells were washed 3x in PBS and 
CD4
+ 
T cell proliferation was assessed by flow cytometry. For co-culture assays, CPEC and 
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AEC were grown in a 24 well plate at 2.5x10
4 
cells/cm
2
 for 72 hours. Violet proliferation dye-
labelled CD4
+ 
T cells were added to the wells in complete RPMI at 6x10
5
 cells/well or 2x10
5
 
cells/culture insert. Cells were then incubated for 96 hours at 37°C. For fixing, cells were 
washed in PBS/2% BSA and incubated in 50µl reagent A (FIX & PERM® cell fixation and 
cell permeabilisation kit; Life Technologies, Invitrogen, Paisley, UK) for 15 min at room 
temperature (RT) prior to a final wash. Cells were analysed immediately or stored at 2-8°C 
for later analysis.  
 
2.8 Migration Assays 
The underside of cell culture inserts (pore diameter 3.0µm, surface area 0.33cm
2
; Sigma 
Aldrich) were coated with 35µl laminin (50µg/ml; Sigma Aldrich) for 2 hours at 37°C and 
washed 3x in distilled water. CPEC/AEC were applied to the underside of the inserts in 50µl 
complete RPMI at 2.5x10
4 
cells/cm
2
 for 1-2 hours to enable loose adherence. Culture inserts 
were gently placed in media the correct way round in a 24 well plate and incubated for 72 
hours at 37°C. Some culture inserts were also used without any cells grown on the underside. 
Culture inserts were placed in fresh wells and 2x10
5
 CD4
+ 
T cells added per insert. Some 
culture inserts were also placed in wells containing CPEC CM or AEC CM, or with CPEC or 
AEC grown in the bottom. Cells were incubated for 4 hours at 37°C and migrated fractions 
were collected. For antibody staining, cells were washed in PBS/2% BSA and for phenotypic 
analysis were incubated with anti-human CD4-PE-Vio770 (clone VIT4, 1/80; Miltenyi 
Biotec), anti-human CD45RA-PE-CF594 (clone HI100, 1/400; BD Biosciences, Oxford, UK) 
and anti-human CCR7-FITC-AlexaFluor 488 (clone G043H7, 1/20; Biolegend, London, UK) 
in PBS/2%BSA + 2.5µM vitamin C for 20 min at RT. Cells were washed in PBS/2%BSA and 
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fixed in 50µl reagent A (Life Technologies, Invitrogen) for 15 min at RT. Cells were washed 
again and analysed immediately or stored at 2-8°C for later analysis. 
 
2.9 Flow Cytometry 
Cells were analysed on a Beckman Coulter CyAn ADP flow cytometer and data was 
processed using Kaluza Flow Cytometry Analysis software v1.2 (Beckman Coulter, High 
Wycombe, UK). CD4
+ 
T cell populations were analysed as percentages rather than actual 
numbers to account for the difficulty in retrieving all of the original cells. 
 
Statistics 
Data were analysed using Graphpad Prism software v5.0 and are presented as mean ± SEM.  
P values of less than 5% (P <0.05) were considered statistically significant.  
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Results 
3.1 CPEC and AEC differ in Morphology 
In vivo CPEC constitute a cuboidal epithelium, however in culture they appeared elongated 
and fibroblast-like; a characteristic generally not associated with epithelial cells (Fig. 1A & 
Fig. 1B). In contrast AEC were typically epithelial, exhibiting the polygonal, cobblestone 
appearance commonly associated with epithelial cells (Fig. 1C).  
 
 
 
 
3.2 Dynabead Titration to Determine the Most Appropriate Cell-to-Bead Ratio 
Anti-CD3/anti-CD28-coated stimulatory beads were used to stimulate CD4
+
 T cells by 
ligating CD3 and CD28 receptors, mimicking stimulation by antigen presenting cells. To 
determine the most appropriate number of beads to produce robust and reproducible CD4
+ 
T 
cell proliferation, a preliminary titration study was carried out using 1:1 to 1:64 cell-to-bead 
ratios (Fig. 2). This also enabled smaller changes in proliferation to be noticeable by 
preventing over-stimulation of CD4
+ 
T cells, which would presumably also cause an increase 
in cell death.  
 
Figure 1. Morphology of CPEC and AEC in culture. Human CPEC at low density (A) and high density (B) 
cultured in EGF-supplemented media exhibit a fibroblast-like morphology. Human AEC cultured in EGF-
supplemented media display the typical cobblestone morphology associated with epithelial cells (C). 
Photographs taken at x10 magnification.  
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As expected, the number of undivided CD4
+ 
T cells increased incrementally with each bead 
dilution. The higher cell to bead ratios such as 1:1 and 1:2 resulted in more of the original cell 
population proliferating, however they also culminated in less cell divisions. Conversely, the 
lower cell-to-bead ratios meant that less CD4
+ 
T cells proliferated, but those that did 
underwent more divisions.  
With the 1:8 ratio, 61% of CD4
+ 
T cells proliferated at least once and 7% of cells underwent a 
total of 5 divisions. Therefore this ratio provided an intermediate level of proliferation 
sensitive to change and was therefore selected for use in future assays. 
 
 
 
 
Figure 2. Titration of anti-CD3/anti-CD28 stimulatory beads. The proliferation of CD4
+
 T cells in response 
to varying dilutions of stimulatory beads over a 96 hour period was determined. A 1:8 cell-to-bead ratio was 
selected as the most appropriate ratio to induce sufficient CD4+ T cell proliferation, enabling stimulated cells to 
undergo more divisions than higher cell-to-bead ratios such as 1:1  (n=1, triplicate wells, mean ± SEM).  
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3.3 CPEC Inhibit CD4
+ 
T Cell Proliferation via Secreted Factors 
The purity of isolated CD4
+ 
T cell populations for each isolation was between 95-98% (Fig. 
3). CD4
+ 
T cells constituted approximately 47-50% of the PBMC population from peripheral 
blood, with approximately 15% of CD4
+ 
T cells constituting the non-retained fraction; 
probably due to incomplete labelling by the CD4 Microbeads.   
 
 
 
To assess the influence of factors secreted by CPEC and AEC on CD4
+
 T cell proliferation, 
proliferation dye-labelled CD4
+ 
T cells were incubated in complete RPMI (control) or CM 
from CPEC or AEC with or without CD4
+ 
T cell activation (Fig. 4A). Cultures were 
incubated for 96 hours prior to analysis of cell proliferation by flow cytometry. In combining 
the data from individual experiments, the positive control (i.e. CD4
+ 
T cell proliferation alone) 
was converted to 100% and all other values converted to a percentage of the control, such that 
any inhibition in proliferation is proportional to the control (Fig. 4B). When incubated in CM 
from CPEC, CD4
+ 
T cell proliferation decreased by 66.7% compared to the positive control. 
Similarly, when incubated in CM from AEC, CD4 cell proliferation shows a decrease of 
65.4%. With the proliferation dye, each peak to the left of the resting cells peak represents a 
Figure 3. Purity of CD4
+ 
T cell fraction post isolation. Representative histograms showing proportion of 
CD4
+ 
T cells in whole PBMC (A) and CD4
+ 
T cell purity post-positive selection (B) from the same donor. 
CD4
+
 expression in the negative fraction post-positive selection was also assessed (C). Gated on total viable 
lymphocytes from forward scatter vs side scatter density plots (n=6). 
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cell population division. The percentage of cells in the viable population in each cell division 
was gated on and converted to average number of divisions. 
Flow cytometry histograms from one representative experiment (Fig. 4C-F) show that the 
percentage of CD4
+ 
T cell proliferation in the positive control (i.e. stimulated CD4
+ 
T cells 
alone) was 93.5% with an average of 2.7 divisions. For stimulated CD4
+ 
T cells in CPEC CM 
proliferation was reduced to 80.7% with 1.9 divisions and for stimulated CD4
+ 
T cells in AEC 
CM proliferation was reduced to 86.9% with 2 divisions. In the resting (i.e. unstimulated) 
CD4
+ 
T cell populations (alone or with CPEC CM or AEC CM) proliferation was <1% and 
the average number of divisions was 0.02 or less.    
 
 
 
 
 
Figure 4. Soluble factors secreted by CPEC and AEC suppress CD4
+ 
T cell proliferation. Resting or 
stimulated CD4
+ 
T cells were incubated in EGF-free complete RPMI collected from CPEC or AEC for 96 
hours (A). Culture of stimulated CD4 cells in the presence of conditioned media (CM) resulted in a 66.7% 
decrease (CPEC) and a 65.4% decrease (AEC) in CD4
+ 
T cell proliferation (B). Data are mean ±SEM and are 
significant to ** (P= <0.01) using a one-way ANOVA and Dunnet’s post-hoc test (independent assays 
repeated in triplicate, n=3-4). Representative frequency histograms showing the proliferation of resting CD4
+ 
T 
cells (C), stimulated CD4
+
 T cells (D), stimulated CD4
+ 
T cells in CPEC CM (E) and stimulated CD4
+ 
T cells 
in AEC CM (F) after a 96 hour incubation period. Cell divisions are represented by peaks increasing from 
right to left.  
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3.4 CPEC Abrogate CD4
+ 
T Cell Proliferation via Cell Contact-Mediated Mechanisms 
The influence of direct contact-mediated mechanisms on CD4
+ 
T cell proliferation was 
determined by culturing proliferation dye-labelled CD4
+ 
T cells directly with CPEC or AEC 
with or without stimulatory beads, and determining proliferation after a 96 hour incubation 
period (Fig. 5A).  
 
 
 
 
 
The combined data from repeated experiments shows that direct contact with CPEC reduced 
CD4
+ 
T cell proliferation by 90.2% whereas direct contact with AEC promoted a 70.8% 
reduction in CD4
+ 
T cell proliferation (Fig. 5B). The average number of CD4
+ 
T cell divisions 
Figure 5. Direct co-culture with CPEC or AEC reduces activated CD4
+ 
T cell proliferation. Resting or 
stimulated CD4
+ 
T cells were co-cultured with CPEC or AEC for 96 hours (A). Direct contact with CPEC or 
AEC significantly inhibited activated CD4
+ 
T cell proliferation (B). Data are mean ±SEM and are significant 
to *** (P= <0.001) using a one-way ANOVA and Dunnet’s post-hoc test (independent assays repeated in 
triplicate, n=3-4). Representative frequency histograms showing the proliferation of resting CD4
+ 
T cells 
(C), stimulated CD4
+ 
T cells (D), stimulated CD4
+ 
T cells cultured in direct contact with CPEC (E) and 
stimulated CD4
+ 
T cells cultured in direct contact with AEC (F). Cell divisions are represented by peaks 
increasing from right to left.   
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in resting (i.e. unstimulated) populations alone or in contact with CPEC or AEC was below 
0.05, therefore resting CD4
+ 
T cell populations were not included in the final analysis. 
Representative frequency histograms show an average number of CD4
+ 
T cell divisions of 2.7 
with 93.5% proliferation for activated CD4
+ 
T cells alone, 0.3 (29.6% proliferation) for 
activated CD4
+ 
T cells in contact with CPEC and 1.1 (79.2% proliferation) for activated CD4
+ 
T cells in contact with AEC (Fig. 5C-F). 
 
3.5 Selective Central Memory T Cell Migration in Inverted Culture 
To mimic the migration of CD4
+ 
T cell subsets in the basolateral-apical direction as observed 
in vivo across the BCSFB, epithelial cells were grown on laminin-coated inserts for 1-2 hours 
prior to returning to the correct orientation for a further 72 hours (Fig. 6A). CD4
+
 T cells were 
added to the inserts and the phenotypes of cells that had migrated through the epithelial layers 
after a 4 hour incubation period was determined by flow cytometry. Since the majority of 
CD4
+ 
T cells in the CSF are of the central memory phenotype, the ability of CPEC to recruit 
central memory CD4
+ 
T cells was investigated, using AEC as a comparison.  
Migrated cells from whole CD4
+ 
T cell populations were characterised by staining for 
CD45RA and CCR7 antigens and assessing by flow cytometry (Fig. 6C-E). Effector memory 
CD4
+ 
T cells (Tem) were classified as CD45RA
-
 CCR7
-
 and central memory CD4
+ 
T cells 
(Tcm) were classified as CD45RA- CCR7
+
. Naïve CD4
+ 
T cells were classified as being both 
CD45RA
+
 and CCR7
+
.   
On average, the relative migration of Tcm was significantly increased from 35% (± 5.1) to 
55% (±7.3) with CPEC on the culture insert and 61% (±2.1) with AEC on the culture insert, 
suggesting preferential recruitment of Tcm. The relative migration of Tem was insignificantly 
affected in the presence of CPEC (11.8% ±3.0) and AEC (12.3% ±2.3) on the culture insert 
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compared to the control, i.e. spontaneous migration (11.4% ±0.8). The relative migration of 
naïve CD4
+ 
T cells was reduced from 55% (±5.3) to 33% (±9.6) when CPEC were grown on 
the underside of the culture insert, and 27% (±4.4) when AEC were grown on the underside of 
the culture insert (Fig. 6B).   
 
 
 
 
 
 
 
 
Figure 6. Inverted culture of CPEC and AEC increased central memory CD4
+ 
T cell migration. The 
phenotype of migrated CD4
+ 
T cells through CPEC or AEC grown on the underside of laminin-coated 
transwell inserts was determined after 4 hours (A). The presence of CPEC or AEC increased Tcm 
migration compared to the control (spontaneous migration; B). Data are means ± SEM and are significant 
to * (P= <0.05) and ** (P= <0.01) using a two-way ANOVA and Tukey’s multiple comparisons test 
(independent assays repeated in singular or duplicate wells, n=3). Representative flow cytometry 
quadrants of an individual experiment showing the proportions of naïve, Tem and Tcm CD4
+ 
cells 
migrated spontaneously through a culture insert (C) or through CPEC (D) or AEC (E) grown on the 
underside of culture inserts. 
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3.6 Conditioned Media from CPEC and AEC Induces Tcm Recruitment 
The influence of CPEC, AEC or soluble factors secreted by both cell types on the migration 
of CD4
+ 
T cell subsets was investigated using transwell culture inserts set up in 24 well plates. 
CPEC or AEC-derived CM was added to the wells (Fig. 7A) or epithelial cells were grown in 
the wells (Fig. 7B) and migrated CD4
+ 
T cells were analysed after 4 hours. 
 
 
 
Figure 7. Secreted factors play a role in epithelial cell-mediated Tcm recruitment. The migration of CD4
+ 
T cells towards CPEC or AEC-derived CM (A) or towards CPEC or AEC growing in the wells (B) was 
investigated. Graph show the average migration of CD4
+ 
T cells through transwell inserts towards CPEC or 
AEC-derived CM, or towards CPEC or AEC in the wells (C).  Data are mean ± SEM and are significant to * 
(P= <0.05) and ** (P= <0.01) using a two-way ANOVA and Tukey’s multiple comparisons test (independent 
assays repeated in single or duplicate wells, n=3-4). Representative flow cytometry quadrants of an individual 
experiment showing the proportions of naïve, Tem and Tcm CD4
+ 
cells migrated spontaneously through a 
culture insert (D), towards CPEC CM (E) or AEC CM (F) or towards CPEC (G) or AEC (H) in the wells. 
- 20 - 
 
Spontaneous migration, i.e. the migration of CD4
+ 
T cells through the culture insert with no 
cells or CM in the well, showed that the migrated cell population constituted 55% (±5.3) 
naïve CD4 cells, 35% (±5.1) Tcm and 11% (±0.8) in a 4 hour period.  
Results show that CM from both CPEC and AEC recruit Tcm and Tem to a lesser extent but 
show a reduction in naïve CD4
+ 
T cell migration (Fig. 7C). The presence of CPEC-derived 
CM in the wells increased Tcm migration to 55% (±7.0; a 20% increase) and Tem migration 
to 22% (±3.9; an 11% increase) of the total migrated CD4
+ 
T cell population. Relative naïve 
CD4
+ 
T cell migration was 23% (±7.4; a 32% decrease). 
Addition of AEC-derived CM to the wells showed similar results, with the migrated 
population constituting 26% (±12.6)  naïve CD4 cells (a 29% decrease), 52% (±13.3) Tcm (a 
17% increase) and 21% (±0.7) Tem (a 10% increase). This appears to suggest that epithelial 
cells employ mechanisms to actively recruit Tcm and Tem. 
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Discussion 
This study sought to investigate the potential of CPEC, which in vivo constitute the BCSFB, 
to influence CD4
+ 
T cell proliferation and migration in direct contact or in the presence of 
secreted soluble factors. AEC were used alongside CPEC as a positive control due to their 
well-documented immunomodulatory properties. Results indicate that both CPEC and AEC 
(1) can modulate the immune response, and (2) influence the migration of CD4
+ 
T cell 
subsets.  
 
4.1 CPEC and AEC Morphology 
In culture, CPEC appeared fibroblast-like and elongated; a characteristic not generally 
associated with epithelial cells. These cells were procured commercially and although they 
had only been previously passaged once, their unusual phenotype could have been a potential 
artefact of culture caused by a high number of cell doublings, which may have promoted 
reversion to a less differentiated phenotype of neuronal origin. These cells had also been 
previously subjected to freezing in liquid nitrogen for transport purposes, which may have 
affected their phenotype. In contrast, AEC exhibited the typical cobblestone morphology 
associated with epithelial cells. AEC were sourced from primary human tissue shortly prior to 
use and were not frozen, which could have contributed to them retaining their phenotypic 
characteristics.  
Interestingly a change in morphology was observed in AEC in contact with activated CD4
+ 
T 
cells; however in the same conditions there was no morphological change in CPEC. The 
cobblestone-like morphology of AEC under resting conditions became star shaped and 
fibroblast-like with numerous protrusions- a previously unreported phenomenon. This could 
reflect the inhibitory capacity of the cells, as this study has shown that AEC-mediated 
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inhibition of activated CD4
+ 
T cells is less potent than CPEC, which appear to readily inhibit 
activated CD4
+ 
T cells. It could be that on stimulation, AEC require the up-regulation of 
inhibitory receptor(s) and signalling proteins required to dampen the immune response which 
could (1) be responsible for the apparently lower inhibitory capacity of AEC, and  (2) cause 
the observed change in morphology. This would also imply that CPEC constitutively express 
the molecules required to inhibit CD4
+ 
T cell proliferation, also reflected by the results of this 
study.   
 
4.2 Mechanisms of Inhibiting CD4
+ 
T Cell Proliferation 
This study has demonstrated that immunosuppressive factors secreted by both CPEC and 
AEC inhibit CD4
+ 
T cell proliferation to a similar degree (approximately 66%), however 
direct contact resulted in an even greater degree of inhibition, with CPEC mediating a 90% 
and AEC a 70% reduction in proliferation. This suggests that the secreted factors responsible 
for this phenomenon could be common to epithelial cells, in part agreeing with previous 
publications documenting inhibition mediated by different types of epithelial cells 
(Cruickshank et al., 2004; Sugita et al., 2009; Qureshi et al., 2010). Direct contact with AEC 
resulted in only a slight increase in CD4
+ 
T cell inhibition, suggesting that AEC-mediated 
effects could be entirely soluble and that the observed improvement in direct contact could be 
a technical effect of using CM, rather than a biological effect. However with such significant 
attenuation of CD4
+ 
T cell proliferation, CPEC-mediated inhibition is difficult to dispute and 
suggests a potent immune-regulatory role for CPEC in terms of both secreted soluble factors 
and direct interaction with CD4
+ 
T cells.  
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4.2.1 Secreted Factors 
The mechanisms mediating CD4
+ 
T cell inhibition remain elusive and are likely complex and 
multi-factorial. Established molecules playing a role in immunomodulation include TGF-β 
and PGE2, however it is possible that other molecules play a role.   
Arginine is required by T cells for a number of important biological functions, including 
proliferation and expression of the T cell receptor (TCR) complex (Ochoa et al., 2001; 
Popovic et al., 2007). One candidate molecule that may contribute to epithelial cell-mediated 
CD4
+ 
T cell inhibition is inducible nitric oxide synthase (iNOS), which catalyses the 
production of nitric oxide from arginine. iNOS is a major mediator in the suppression of T 
cell proliferation by some cell types such as mesenchymal stem cells (MSC) and its 
production has been reported in retinal pigmented epithelial cells in response to activated T 
cells, thus it is plausible that CPEC and/or AEC may employ iNOS to the same effect 
(Liversidge et al., 1994; Sato et al., 2007). Arginine depletion is also mediated by arginase 
and though the induction of iNOS or arginase blocks T cell proliferation, simultaneous 
induction of both enzymes results in T cell apoptosis, which appeared to be increased in 
CPEC and AEC CM (Bronte et al., 2003). Analysing the CM for these metabolites or 
enzymes would indicate whether any of these mechanisms are at play.  
Another molecule implicated in immune regulation is indoleamine 2,3-dixoygenase (IDO). 
IDO expression has been detected in the brain and at the maternal-foetal interface, thus it is 
possible that CPEC and AEC limit T cell proliferation by producing this enzyme, which 
restricts the availability of the essential amino acid tryptophan in the local environment 
(Ligam et al., 2005; Kwidzinski et al., 2007). Analysing the extent of apoptosis by 
quantification of dead cells wouldn’t address which molecules are involved but may provide 
some information on the mechanisms involved. 
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AEC also secrete interleukin-10 (IL-10), vascular endothelial growth factor (VEGF) and 
soluble human leukocyte antigen-G (sHLA-G), a non-classical class I antigen exclusively 
expressed by placental and thymic cell types with a role in immune tolerance (Bogic et al., 
2000; Lefebvre et al., 2000; Li et al., 2005). Reflecting their function as facilitators of 
neuronal growth, CPEC have been documented to secrete nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF) and other neurotrophins as well as interleukin-6 (IL-6) 
and basic fibroblast growth factor (bFGF) (Yamamoto et al., 1996; Vallieres et al., 1997; 
Chodobski et al., 2001; Borlongan et al., 2004). Thus although both CPEC and AEC likely 
secrete a range of common immunomodulatory factors, it is difficult to know how conserved 
the immunosuppressive response is amongst epithelial cell types. The developmental origin, 
location and function of the cells in vivo could therefore influence the molecules that are 
secreted. Furthermore, a distinction must be made between molecules the cells can secrete 
and molecules the cells do secrete on contact with T cells. 
 
4.2.2 Cell-bound Mechanisms 
In addition to soluble factors, negative signals delivered to T cells by cell-bound counter-
regulatory molecules contribute to the tight regulation of the immune system. Such rapid and 
deliberate responses are vital to maintaining the delicate balance between resting and 
inflammatory conditions.  
 
4.2.2.1 Induction of Anergy 
Dysregulated lymphocyte migration across the BCSFB could be of potential danger so must 
be tightly regulated. Though it is possible that both types of anergy (clonal anergy and 
adaptive tolerance) may exist in the same environment, the findings in this report suggest that 
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the CD4
+ 
T cells are inhibited on activation, since resting CD4
+ 
T cells in contact with CPEC 
or AEC do not appear to be adversely affected compared to the control. Also, the anti-
CD3/anti-CD28-coated stimulatory beads provide both signals required for complete CD4
+ 
T 
cell activation; thus clonal anergy can be disregarded as a mechanism of inhibition.  
Naïve CD4
+ 
T cells constitute approximately 30% of the total CD4
+ 
T cell population so their 
inhibition would theoretically still enable 70% of CD4
+ 
T cells to proliferate. In this study 
direct contact with CPEC inhibited the proliferation of over 90% of the total CD4 cell 
population, thus ruling out adaptive tolerance as the major mechanism of CD4
+ 
T cell 
inhibition. This supports findings from a previous study, which demonstrated that colonic 
epithelial cells inhibit CD4
+ 
T cell proliferation but do not induce anergy (Cruicksank et al., 
2004).  
 
4.2.2.2 Death Receptors 
Previous work has shown that AEC mediate apoptosis by FasL and TRAIL signalling, thus 
maintaining a state of immune privilege (Li et al., 2005). Though FasL is expressed in the 
brain and spinal cord, it is not expressed in the choroid plexus (French et al., 1996; Bechmann 
et al., 1999), leading to the suggestion that different areas of the CNS may employ different 
mechanisms of regulating the immune system. This could offer a fail-safe mechanism such 
that if one of these regulatory pathways was defective, an alternative would be available; a 
logical possibility considering the damaging consequences of CNS inflammation.  
 
4.2.2.3. PD-1-PD-L1 Signalling 
Since it appears that FasL probably does not play a role in CPEC-mediated inhibition, other 
receptor-dependent mechanisms must be explored.  
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As the counter-regulatory molecule PD-L1 has been previously implicated as a mechanism of 
immunomodulation by various epithelial cell types, it is possible that this molecule is also 
responsible for regulating immune responses by CPEC (Cruickshank et al., 2004; Beswick et 
al., 2007; Heinecke et al., 2008; Sugita et al., 2009). Blocking the PD-L1 target PD-1 in mice 
promotes the development of autoimmune diseases by inducing a chronic breakdown of 
peripheral self-tolerance, suggesting that the PD-1-PD-L1 pathway is important in preventing 
autoimmune conditions (Nishimura et al., 1999; Nishimura et al., 2001). Further evidence for 
the involvement of this pathway in the CNS comes from Salama et al., who found that 
blocking PD-1 resulted in increased autoreactive T cells in the CNS which contributed to 
EAE (Salama et al., 2003). Though their results show that PD-L1 is expressed in the brains of 
mice, the specific location of PD-L1 expression is not established so it remains unknown 
whether this receptor is expressed by CPEC.  
 
4.2.2.4 Alternative Mechanisms of Inhibition 
It could be that CPEC employ unidentified mechanisms to inhibit T cell proliferation. 
Recently identified members of the CD28/B7 superfamily, including V-set and Ig domain-
containing 4 (VSIG4), B and T lymphocyte attenuator (BTLA), B7-H3 and B7-H4, are co-
inhibitors of T cell proliferation and give an insight into the complexity of cell signalling 
pathways but also raise the possibility of other previously unidentified inhibitory receptors 
playing a role (Watanabe et al., 2003; Vogt et al., 2006; Kryczek et al., 2006; Leitner et al., 
2009). 
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4.3 Preferential Immune Cell Recruitment Mediated by Epithelial Cells 
This study sought to better understand the relationship between naïve, central memory and 
effector memory CD4
+ 
T cell subsets with CPEC to help elucidate the complex nature of 
lymphocyte trafficking across the choroid plexus. As a well-established immunomodulatory 
cell type providing immune privilege in vivo, AEC were used as a comparison. Results from 
this study suggest that CPEC and AEC actively recruit Tcm and to a lesser extent Tem. 
The findings that less Tcm migrated towards CPEC and AEC growing in the wells than 
towards CM is difficult to explain. These effects were presumably due to soluble factors, and 
it may be that the presence of CD4
+ 
T cells induced a downregulation in the chemotactic 
molecules secreted by the epithelial cells. Inverted culture appeared to promote Tcm 
migration more than standard culture, suggesting that the mechanisms involved may be more 
strongly mediated via the basolateral surface of epithelial cells rather than the apical surface.  
 
4.3.1 Promoting Tcm Recruitment 
As previously mentioned, CM contains a host of soluble factors and cytokines which may 
have promoted specific chemoattraction of Tcm. This would be advantageous in the context 
of immune privilege for a number of reasons: (1) memory T cells in general are experienced 
and have previously encountered antigen, (2) Tcm have less effector function at rest (as 
compared to Tem) and (3) Tcm can rapidly proliferate and differentiate into effector cells on 
encountering antigen (Berard & Tough, 2002). The idea that AEC could differentially recruit 
Tcm has not previously been explored but considering their requirement to promote immune 
privilege at the foetal-maternal interface, preferential Tcm recruitment would appear 
beneficial. 
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4.3.1.1 Chemokines involved in Selective Tcm Recruitment 
Tcm express the homing chemokine CCR7 on their surface, which can be used to gain access 
to the CNS via CCL21 expressed constitutively on the choroid plexus (Kivisakk et al., 2003). 
However, CCR7 is also expressed by naïve T cells and transiently by Tem on activation, so 
although this pathway is certainly a route for lymphocyte trafficking, it seems unlikely to be 
responsible for selective Tcm recruitment (Sallusto et al., 1999; Rot et al., 2004). 
IFN-γ signalling, which has recently been implicated in leukocyte trafficking across the 
BCSFB, may play a role in Tcm migration into the CNS (Kunis et al., 2013). 
It is reported that the majority of T cells in the CSF express the chemokine receptor CXCR3, 
which is involved in immune surveillance, regardless of disease status (Kivisakk et al., 2002).  
Since the majority of T cells in the CSF are CD4
+
 Tcm, it is possible that these cells are 
granted entry into the CNS through CXCR3-dependent mechanisms mediated by cytokines 
secreted by epithelial cells. CXCL9 and CXCL10, two of the chemokines that bind CXCR3, 
are constitutively expressed by human intestinal epithelial cells and CXCL9 is also expressed 
constitutively by epithelial cells lining the male urogenital tract (Linge et al., 2008), raising 
the possibility of CXCL9 or CXCL10 expression by CPEC or AEC.  
 
4.3.1.2 Adhesion Molecules involved in Selective Tcm Recruitment 
The presence of a P-selectin-expressing subset of memory CD4
+
 T cells in the peripheral 
blood suggests that this subpopulation may be granted unlimited access to the CNS via P-
selectin-mediated trafficking across the choroid plexus (Kivisakk et al., 2003). As tissue-
specific lymphocytes have previously been described this raises the possibility that CNS-
specific lymphocytes also exist, and it may help explain the distinction between immune 
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surveillance, where tissues are routinely patrolled, and inflammation, mediated by T cells 
non-specific to the CNS and thus have never encountered CNS antigens (Cose 2007).  
In the BCSFB, CPEC are polarised so that lymphocyte trafficking occurs in the basolateral to 
apical direction. Selective recruitment would imply that CPEC exert this function from their 
basolateral side; however CPEC are adhered to a basal lamina thus presumably imposing 
restrictions on the secretion or expression of regulatory molecules. As such, it could be that 
initial migration is non-specific and that phenotypic modulation occurs during migration, 
ensuring that any cell entering the CNS is modified to the requirements dictated by CPEC.  
Because of the range of chemokines, cytokines and adhesion molecules known to contribute 
to homeostatic leukocyte trafficking into the CNS, it is likely that a combination of molecules 
is required to produce the correct ‘entry code’ for specific immune cell subsets. 
 
4.4 Assay Refinements and Future Work 
4.4.1 Effects of Culture Conditions on Epithelial Cells 
Though not relevant to the in vivo characteristics of the cells, understanding the influence of 
extended passage number or prolonged culture on the phenotype and function of CPEC and 
AEC would help identify artefacts induced by these conditions, which can be addressed and 
rectified in future studies to make them more physiologically relevant. Ideally, prolonged 
culture should be avoided and cells should be used at low passage but practically this may be 
difficult so understanding more about the effects of prolonged culture is important for 
optimising in vitro studies.  
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4.4.2 Improving the Proliferation Assays 
Some unrecoverable adherent CD4
+ 
T cells were observed in co-culture were observed, 
possibly causing selective harvesting and leading to experimental bias. However prior to 
harvesting the CD4
+ 
T cells there was no visible CD4
+ 
T cell proliferation in contact with 
CPEC, suggesting that the biological mechanisms are true and that further protocol 
refinements are required. Harvesting the epithelial cells from each well and then purifying the 
CD4
+ 
T cells may ensure a better recovery rate. 
 
4.4.3 Real-Time Analysis of the Influence of Secreted Factors on Proliferation 
Demonstrating a direct biological effect rather than a metabolic effect, i.e. caused by the 
depletion of nutrients, may be difficult. To analyse the effects of secreted factors in real-time, 
a culture insert permitting the diffusion of soluble factors but preventing cell migration could 
be used, with the epithelial cells grown in the well and the CD4
+ 
T cells added to the culture 
insert. These inserts are available commercially and typically come with a pore size of 0.4µm. 
Though this current study has shown that factors secreted by CPEC and AEC significantly 
reduce CD4
+ 
T cell proliferation, the described transwell system would likely provide a more 
accurate account of the degree of inhibition and could be employed in future studies. 
 
 
 
4.4.4 Investigating the Expression Characteristics of Inhibitory Molecules 
Future work could investigate the time course of CD4
+ 
T cell inhibition which may help to 
elucidate the expression characteristics of the inhibitory molecules involved, i.e. whether their 
expression is constitutive or induced. To analyse the potency of secreted factors, CD4
+ 
T cells 
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could be incubated in varying concentrations of CM to determine the minimum threshold 
required to inhibit CD4
+ 
T cell proliferation. Multiplex ELISA or mass spectrometry could be 
employed to elucidate the components of CPEC and AEC-derived CM, and gene expression 
analysis of CPEC and AEC in contact with resting and stimulated CD4
+ 
T cells may reveal the 
expression characteristics of any inhibitory molecules or receptors.    
 
4.4.5 Investigating the Mechanisms of Epithelial Cell-Mediated Inhibition 
Though inhibition of CD4
+ 
T cell proliferation by epithelial cells has been widely reported, 
the precise mechanisms remain elusive. Further studies could investigate whether inhibition is 
reversible by culturing stimulated CD4
+ 
T cells with CPEC for a period of time, harvesting the 
CD4
+ 
T cells and restimulating in the absence of CPEC. This would demonstrate whether the 
CD4
+ 
T cells have been rendered anergic or if they are still responsive and are able to 
proliferate. The latter case would suggest that CPEC enable CD4
+ 
T cells to retain their 
functions but are temporarily ‘dampened’ in their presence. 
It is possible that certain CD4
+ 
T cell subsets, such as naïve CD4
+ 
T cells, are more amenable 
to inhibition than others. Repeating the assays with purified CD4
+ 
T cell subsets and 
restimulating the CD4
+ 
T cells after an initial stimulation period would show whether 
epithelial cells are selective in their inhibition.     
 
 
4.4.6 Improving the Inverted Co-Culture Model 
Inverted co-culture is intended to be physiologically representative of the BCSFB so that 
CD4
+
 T cell migration occurs in the basolateral to apical direction, as it occurs in vivo. An 
important feature of the BCSFB is the presence of tight junctions (TJ), providing a physical 
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barrier between the CNS and the periphery with proteins such as occludin, claudin-1 and ZO-
1 (Johanson et al., 2011). Ideally, a monolayer of epithelial cells would have formed on the 
underside of the insert.  The integrity of the epithelial layer can be assessed by measuring the 
trans-epithelial electrical resistance (TEER) or by assessing the permeability of the barrier to 
macromolecules such as dextran (Tenebaum et al., 2013), and monolayer formation may be 
improved by reducing serum and calcium concentrations in the media (Chang et al., 1997). 
Also, cutting out the culture insert and staining the epithelial cells for TJ proteins would have 
revealed more information on the barrier characteristics and the arrangement of epithelial 
cells. 
Though this study modelled lymphocyte migration across a model of the BCSFB, trafficking 
into the CNS is comprised of multiple barriers and a multi-tiered transwell system mimicking 
endothelium, a matrigel-like component to replace the stroma and finally the CPEC of the 
BCSFB may be more accurate in replicating the complex in vivo system and may also 
demonstrate a role for endothelium.  
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Conclusions 
A number of candidate molecules exist that could be responsible for CPEC-mediated CD4
+ 
T 
cell inhibition, though it is unlikely that any one molecule is entirely accountable for this 
effect.  Rather, it appears that CPEC and AEC exhibit a multi-factorial approach to regulating 
the immune system with evidence for the involvement of both soluble factors and direct 
contact-dependent mechanisms. Though evidence exists for the inhibition of T cell 
proliferation by other types of epithelial cells, it is unclear whether epithelial cells from 
different sources harbour similar abilities to modulate the immune response or whether those 
derived from immune privileged sites are more highly specialised.  
Due to the high numbers of CD4
+ 
Tcm present in the CSF, preferential recruitment of Tcm 
has been implicate for CPEC, but this phenomenon is previously undocumented for AEC (de 
Graaf et al., 2011). Thus it seems that immune privileged sites may universally employ this 
mechanism of immune surveillance, giving a new dimension to the term ‘immune privilege’.  
Understanding a biological system under normal conditions is equally as important as 
understanding the same system in disease. A greater appreciation of lymphocyte trafficking 
and the events that occur at the BCSFB may enhance our understanding of inflammatory 
conditions of the CNS, such as multiple sclerosis. Furthermore, readily available 
immunomodulatory cells have generated interest for their therapeutic potential, providing a 
great deal of scope for further studies.  
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Abstract 
Mesenchymal stromal cells (MSC) from different sources may possess enhanced properties 
over others. Furthermore, ultrasound is a potential tool to influence cell behaviour. MSC from 
adult (bone marrow, adipose and dental pulp) and foetal (amnion) sources were compared and 
the effects of ultrasound were investigated. 
The proliferation, osteogenic and adipogenic differentiation potential, expression of 
immunomodulatory (TGF-β1, IL-10, COX-2) and stemness (Oct-4, nanog) genes and 
secretion of VEGF, BDNF and TGF-β1 was assessed. Proliferation, gene expression and 
cytokine secretion 48 hours after a single 5 min ultrasound treatment (1MHz, 250mWcm
-2
) 
was also determined. 
Dental pulp-MSC had the highest proliferative capacity but the lowest differentiation 
potential. Bone-marrow-MSC had the lowest proliferative capacity but highest differentiation 
potential along with adipose-MSC, and secreted high levels of VEGF. Amnion-MSC 
possessed the highest osteogenic potential, expressed both immunomodulatory and stemness 
genes moderately and secreted highest levels of TGF-β1 and BDNF. Ultrasound has no effect 
on proliferation and had mostly opposing effects on gene expression in dental pulp-MSC and 
adipose-MSC, but increased VEGF secretion. 
MSC from different sources possess specialised characteristics, and may be preferentially 
selected based on the desired application. Ultrasound may enhance immunomodulatory and 
stemness properties of some MSC types for experimental or therapeutic use. 
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Introduction 
1.1 What are Mesenchymal Stromal Cells? 
Mesenchymal stromal cells (MSC) are a heterogeneous population of multipotent cells well 
known for their self-renewing abilities, cytoprotective properties and potent 
immunomodulatory capacity, interacting with both innate and adaptive arms of the immune 
system through numerous soluble and cell-bound factors (Uccelli et al., 2008; Le Blanc et al., 
2012).Originally identified by Friedenstein et al in 1968, MSC isolated from the bone marrow 
were described as colony forming unit-fibroblasts (CFU-F) and have since been extensively 
characterised, though their precise nature remains elusive (Friedenstein et al., 1968).  
 
1.2 Properties of MSC from Different Sources 
Due to their presence in the stromal compartment of almost all tissues (da Silva Meirelles et 
al., 2006), MSC can be isolated from a wide variety of sources, the most common of which 
are bone marrow (Quiroz et al., 2008), adipose tissue (Fraser et al., 2006) and peripheral 
blood (Chong et al., 2012) with alternative sources including muscle (Young et al., 2001), 
heart (Beltrami et al., 2003), synovium (de Bari et al., 2001) and lung (Griffiths et al., 2005). 
MSC have more recently been derived from birth-associated ‘discard’ tissues including the 
placenta, umbilical cord and foetal membranes and with simple non-invasive retrieval, 
plentiful supply and no ethical constraints, holds a number of benefits over conventionally 
sourced MSC (Soncini et al., 2007). Furthermore, there is evidence that MSC of a foetal 
origin possess enhanced proliferative capacity, lower immunogenicity and superior 
immunosuppressive properties compared to adult MSC, making them more attractive for cell-
based therapies (Kern et al., 2006; Deuse et al., 2011). Donor age also affects MSC plasticity, 
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with the differentiation potential of MSC decreases as donor age increases (D’Ippolito et al., 
1999).  
MSC secrete a wide range of growth factors and cytokines which are largely responsible for 
their immunomodulatory and cytoprotective qualities. These include angiogenic growth 
factors such as vascular endothelial growth factor (VEGF), neurotrophins such as brain-
derived neurotrophic factor (BDNF), and immunomodulatory cytokines such as transforming 
growth factor-β1 (TGF-β1) amongst many others (Hass et al., 2011; Lopatina et al., 2011).  
However it is unknown whether the location of MSC in vivo influences the MSC ‘secretome’, 
or whether all MSC secrete the same molecules to the same degree. 
The proliferative capacity of MSC may depend on their location and function in vivo. A 
previous study found that adipose-derived MSC (ADSC) from the subcutaneous adipose 
region proliferated faster compared to those derived from the omental region, suggesting that 
there are variations even within MSC derived from the same source (van Harmelen et al., 
2004). Cell density in vivo could also determine proliferative capacity – if one tissue has 
relatively high numbers of MSC then proliferation may be lower, but another tissue with 
relatively low numbers of MSC may require higher turnover. Furthermore, proliferation of 
some cell types such as bone marrow-derived MSC (BMSC) is limited by contact inhibition 
in culture, whereas other cell types such as dental pulp-derived MSC (DPSC) appear to grow 
by multi-layering, thus enabling cell number to rapidly increase (Baksh et al., 2007). The 
lower proliferative capacity of BMSC has been reported on multiple occasions, and it has 
been suggested that other MSC such as ADSC may be preferable over BMSC where large 
numbers are required (D’Ippolito et al., 1999; Kern et al., 2006).  
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Because amnion is a temporary tissue existing for only nine months in vivo, amnion-derived 
MSC (AMSC) may have a different proliferative capacity compared to adult MSC. During 
development AMSC must proliferate rapidly as the amnion grows and by the third trimester 
are likely very slow at proliferating or even cease to proliferate completely, again providing 
evidence that MSC derived from the same tissue may exhibit variable characteristics (Guillot 
et al., 2007). However there is conflicting evidence in the literature regarding AMSC 
proliferation. A number of groups have reported that AMSC from term amnion undergo cell 
death after only 4-5 passages in culture (Portmann-Lanz et al., 2006; Soncini et al., 2007) 
however others have reportedly maintained AMSC for over 15 passages and describe a high 
proliferative capacity (Kim et al., 2007, Ilancheran et al., 2009), thus it is likely that donor 
variability and tissue age is important to this phenomenon.   
 
1.3 Expanding MSC in Culture 
Often, the isolation of MSC alone is not sufficient to generate enough cells for experimental 
or therapeutic use; therefore MSC must be readily expandable in culture. This may be 
achieved by supplementing culture media with growth factors such as epidermal growth 
factor (EGF) and fibroblast growth factor (FGF); a practice known as ‘ex vivo expansion’, 
which has been applied to increase MSC proliferation (Lindenmair et al., 2012). 
Basic FGF (bFGF) is the most common media supplement for MSC and in addition to 
increasing proliferation, is said to increase the immunomodulatory potential of MSC by 
upregulating HLA-class I and HLA-DR expression; however it is also reported that bFGF 
leads to a limited differentiation capacity and shortening of MSC in culture (Sotiropoulou et 
al., 2006). EGF is also a common media supplement for MSC expansion and studies have 
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shown that EGF not only enhances MSC proliferation, but also the differentiation potential, 
motility and paracrine activities of MSC, potentially making MSC more valuable for 
therapeutic use (Tamama et al., 2010). It is unclear whether MSC from different sources 
respond to mitogenic stimulation to the same degree.  
 
1.4 Clinical Applications of MSC 
MSC are an exciting prospect for cell-based therapies and an extensive list of on-going 
clinical trials using MSC-based therapy to ameliorate diseases exists. Most commonly, MSC 
are studied as potential treatments for bone and cartilage disease, heart disease and graft-
versus-host disease, but also liver disease, brain disease, diabetes and multiple sclerosis 
(Wang & Zhao, 2012; Kim & Cho, 2013). Clinical interest in MSC is generally attributed to 
their immunomodulatory and cytoprotective properties but also to their ability to home to 
tumours when injected intravenously, making them an exciting prospect for anti-cancer 
treatment (Reagan & Kaplan, 2011). Furthermore, even though alternative cell types such as 
embryonic stem cells possess a superior proliferative and regenerative capacity to MSC, their 
embryonic nature means they are less differentiated and more susceptible to teratoma 
formation, whereas MSC are generally considered safe for use in humans (Sohni & Verfaillie, 
2013). However, differences in the tissue source and culture conditions of MSC has 
sometimes led to differing or even conflicting evidence in the literature, posing a challenge 
for the therapeutic use of MSC (Sohni & Verfaillie, 2013).  
 
 
- 5 - 
 
1.5 Therapeutic Ultrasound  
Ultrasound is a mechanical force which can stimulate a range of biological effects in cells and 
tissues. It consists of mechanical vibrations of an inaudible frequency generated by the 
conversion of electrical energy to acoustic energy through a piezoelectric transducer, resulting 
in the transmission of acoustic waves (Speed 2001). The therapeutic potential of ultrasound 
and its ability to induce lasting changes in biological systems was first identified in 1927 by 
Wood and Loomis (Wood & Loomis, 1927) and since then, extensive research has culminated 
in the use of ultrasound in over a million NHS treatments annually (Ter Haar et al., 1985).  
Ultrasound is generally divided into two powers; high intensity (~1000Wcm
-2
), which 
obliterates focussed regions of cells or tissues by generating high temperatures, and low 
intensity (~100mWcm
-2
), which generates less focussed pulses that penetrate tissues more 
deeply (Ter Haar 2007). Low intensity pulsed ultrasound (LIPUS) is considered therapeutic 
when administered in the range of 0.75-3MHz (Speed 2001) and in contrast to high intensity 
ultrasound is associated with non-thermal effects such as acoustic streaming and cavitation 
(Dyson 1982).  
 
1.6 Cellular Effects of Therapeutic Ultrasound 
Aside from its clinical use, mainly in treating bone fractures but also in tissue healing, cancer 
therapy and soft tissue stimulation, ultrasound has also been used on cell cultures to stimulate 
a variety of responses (Claes & Willie 2007; Paliwal & Mitragotri 2008). Ultrasound has been 
applied extensively to induce chondrogenesis in MSC for tissue engineering purposes or to 
increase proliferation as a means of ex vivo expansion, usually using BMSC but more recently 
using ADSC as an alternative because of their abundance and accessibility (Gimble 2003). As 
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well as structural alterations on a cellular level, ultrasound is associated with a range of 
stimulatory effects including increased secretion of enzymes, growth factors, chemicals and 
structural proteins in a variety of cell types (Nolte et al., 2001; Chang et al., 2002; Altland et 
al., 2004; Chiu et al., 2008). For example, it is widely reported that ultrasound increases 
VEGF and TGF-β1 secretion, with a dose-dependent effect of TGF-β1 secretion observed 
(Reher et al.,1999; Li et al., 2003; Harle et al., 2005; Leung et al., 2006; Lu et al., 2008; 
Khanna et al., 2009)  
Previous studies have reported that ultrasound increases cell proliferation to varying degrees, 
however because of the variability in frequency, intensity, exposure times and cell types, this 
data is difficult to compare (Man et al., 2012; Ghorayeb et al., 2013). One study found that 
exposing human umbilical cord-derived MSC to a single application of ultrasound increased 
cell proliferation by 3 fold during a 5 day period, but repetitive treatments reduced 
proliferation and viability (Yoon et al., 2009). A more recent study reported similar findings; 
that shorter, single applications of ultrasound increased proliferation whereas long or 
repetitive treatments reduced proliferation in human DPSC (Al-Daghreer et al., 2012).  
Many reports have indicated that ultrasound has no adverse effect on cell viability, however 
some reports have indicated an enhancement of viability after ultrasound treatment, including 
in human BMSC, by inhibiting the expression of apoptosis-related genes (Zhang et al., 2003; 
Lee et al., 2007; Choi et al., 2011; Kang et al., 2011; Man et al., 2012).  
It is clear that much of the literature surrounding the effects of ultrasound on cell cultures is 
inconsistent and conflicting due to the wide range of frequencies, intensities, exposure times, 
treatment pattern (single or repetitive) and cell types used and is thus difficult to compare.  
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1.7 Aims and Hypothesis of the Study 
The hypothesis of this study was that foetal-derived MSC possess better proliferative and 
differentiation capacities than adult MSC, and that administration of therapeutic ultrasound to 
MSC would alter their stemness and immunomodulatory properties.  
This study aimed to characterise MSC derived from adult sources (bone marrow, adipose 
tissue and dental pulp) and from a foetal source (amnion) by investigating characteristics in 
culture (i.e. morphology and growth characteristics), ex vivo expansion potential using media 
supplements and multi-lineage differentiation potential. The influence of therapeutic 
ultrasound on the expression of immunosuppressive and stem cell genes (including TGF-β1 
and Oct-4) and the secretion of immunomodulatory growth factors was also investigated. 
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Methods 
2.1 Isolation of Human Amniotic Mesenchymal Stromal Cells (AMSC) 
Human AMSC were isolated from placentae collected from healthy donors following elective 
caesarean section with informed written consent and Local Research Ethics Committee 
approval. Isolation was conducted following a well-established protocol (Soncini et al, 2007).  
 
2.2 Cell Culture 
Pooled BMSC, ADSC (both Lonza, Basel, Switzerland), DPSC (AllCells L.L.C., Alameda, 
CA, USA) and AMSC were cultured in high glucose Dulbecco’s Modified Eagle Medium 
(HG-DMEM; Biosera, Boussens, France) supplemented with 10% foetal bovine serum (FBS), 
1% penicillin-streptomycin, 1% amphotericin B and 200mmol/L L-glutamine (all Sigma 
Aldrich, St Louis, MO, USA) at 37°C in a humidified atmosphere with 5% CO2. Medium was 
changed every 3-4 days and cells were sub-cultured when 70-90% confluent.  
 
2.3 Proliferation Assay to assess Ex Vivo Expansion Potential 
Cells were grown in 6 well plates at 9.25x10
4
 cells/well in standard growth media described 
above either alone or with the addition of 10ng/ml human Epidermal Growth Factor (EGF; 
Peprotech, London, UK) or 10ng/ml human basic Fibroblast Growth Factor (bFGF; 
Peprotech). Cultures were maintained at 37°C for 7 days and cell number was determined 
microscopically. 
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2.4 Multi-lineage Differentiation Assays 
For osteogenic differentiation, cells were grown in 12 well plates in osteogenic media 
containing 10
-9
 dexamethasone, 10mM β-glycerophosphate and 50µg/ml ascorbic acid (all 
Sigma Aldrich) for 21 days at 37°C, with medium changes every 3-4 days. After one week, 
media was changed from growth media containing 10% FBS to maintenance media 
containing 5% FBS. At day 21 cultures were washed 3x in phosphate buffered saline (PBS), 
fixed in 10% v/v neutral buffered formaldehyde (Leica Biosystems Ltd, Peterborough, UK) 
and incubated in 2% Alizarin Red S (BDH Laboratory Supplies, Poole, UK) at room 
temperature for 20 min with gentle agitation. Alizarin Red was made up in distilled water to 
pH 4.2 using acetic acid. Wells were washed 3x in distilled water and visualised using a Carl 
Zeiss Primo Vert microscope equipped with an AxioCam ERc5s camera (Carl Zeiss 
Microscopy Ltd, Cambridge, UK). Mineralisation was quantified by counting the number of 
nodules in four fields of view per well.  
For adipogenic differentiation, cells were grown in 12 well plates in adipogenic media 
containing 0.5mM 3-isobutyl-1-methylxanthine, 0.5µM hydrocortisone and 1µg/ml insulin 
(all Sigma Aldrich) at 37°C, with medium changes every 3-4 days. After one week, media 
was changed from growth media containing 10% FBS to maintenance media containing 5% 
FBS. On day 21, cultures were fixed in 10% formaldehyde, washed 3x in PBS and stained 
with Oil Red O (BDH Laboratory Supplies). To make the stock solution, 0.25g Oil Red O 
was dissolved in 100ml isopropanol (VWR International S.A.S, Fontenaye-sous-Bois, France) 
for 1 hour at 56°C and filtered when cool to remove any undissolved dye. A working solution 
consisted of 2 parts distilled water mixed with 3 parts Oil Red O stock solution. Finally, wells 
were washed 3x in PBS and visualised under the microscope.   
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2.5 Ultrasound Treatment 
Cells were grown in 6 wells plates at 1.25x10
5
 cells/well for 48 hours. Medium was replaced 
with 9ml fresh medium per well to enable immersion of the transducer head. Plates were 
placed in a custom-made silicone support filled with sterile, room temperature distilled water. 
Ultrasound was generated by a DuoSon; a commercially available therapeutic device 
programmed to transmit ultrasound at different frequencies and intensities (SRA 
Developments Ltd & Orthosonics Ltd, Devon, UK). For this study the DuoSon was used in 
‘mode 1’, emitting a frequency of 1MHz and an intensity of 250mWcm-2 spatial average 
temporal average (SATA). Prior to ultrasound treatment, the transducer head was submerged 
in 70% ethanol for a minimum of 1 hour, washed with sterile medium and allowed to air dry 
under sterile conditions. The transducer was then placed in a metal ring clamped to a stand to 
enable insertion into the culture wells. Sham control plates were subjected to the same 
treatments and were placed in the water bath for the same time are their matched control plate, 
but with the ultrasound transducer switched off.  
To investigate the effects of different ultrasound exposure times on cell proliferation and 
viability, cells were grown in 6 well plates at 9.25x10
4
 cells/well and exposed to ultrasound 
for 1, 3 or 5 min. Cells were harvested after 96 hours and proliferation and viability assessed 
by microscopy and trypan blue staining.  
To investigate the effects of ultrasound treatment on gene expression and cytokine secretion, 
cells were grown in 6 well plates at 1.25x10
5
 cells/well and allowed to adhere for 48 hours 
prior to ultrasound exposure. Cells were exposed to 5 min ultrasound per well and 5ml 
medium was removed to leave 4ml per well. Cells were incubated for 48 hours at 37°C, 
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conditioned media (CM) was collected for analysis of cytokine secretion and cells were 
harvested and pooled for PCR (see below).  
 
2.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
CM was collected from cells growing in 6 well plates 48 hours after ultrasound treatment, 
with corresponding sham controls. CM was also collected from confluent cell cultures 
growing in standard culture flasks. To obtain CM, supernatants were centrifuged at 3000rpm 
for 10 min, decanted into a fresh tube and stored at -20°C until needed. VEGF, BDNF and 
TGF-β1 secretion was analysed by ELISA (R&D Systems, Abingdon, UK) following the 
manufacturer's instructions.  
 
2.7 Semi-Quantitative Polymerase Chain Reaction (PCR) 
RNA isolation was achieved using the RNeasy Mini Kit (Qiagen, Manchester, UK) following 
the manufacturer’s instructions. cDNA was synthesised from the RNA templates using a 
Tetro cDNA synthesis kit (Bioline, Taunton, MA, USA) and cDNA was concentrated by 
washing in RNase-free water in microcon filters (Merck Millipore, Darmstadt, Germany). 
PCR was achieved by mixing an optimal volume of cDNA with RedTaq ReadyMix (Sigma 
Aldrich) and forward and reverse primers (Life Technologies, Invitrogen, Paisley, UK) to 
obtain a total reaction volume of 25µl and samples were processed on a GeneAmp PCR 
System 2700 (Life Technologies, Invitrogen). cDNA was normalised using the housekeeping 
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) to ensure uniform band 
intensities where possible before performing PCR with the primers of interest.  
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Samples were run on a 1.5% agarose gel containing ethidium bromide (Sigma Aldrich) for 
20-30 min at 120 volts. Semi-quantification of bands was achieved using GeneSnap and 
GeneTools image analysis software (Syngene, Cambridge, UK).   
 
2.8 Statistics 
Data were analysed using Graphpad Prism software v5.0 and are presented as mean ± SEM 
where n= >1, or mean ± standard deviation where n=1 and repeats were within a single 
experiment.  P values of less than 5% (P <0.05) were considered statistically significant.  
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Results 
3.1 MSC Morphology and Growth Characteristics in Culture 
At low density DPSC appear long, thin and small in comparison to the other MSC (Fig. 1A). 
However, they proliferated very quickly and as a confluent monolayer appeared 
homogeneous, forming hair-like, wavy patterns. In contrast, BMSC appeared spindly and 
curvy when sparse but when confluent formed a mixture of irregular-shaped cells, suggesting 
a heterogeneous population (Fig. 1B). ADSC (Fig. 1C) and AMSC (Fig. 1D) also appeared 
heterogeneous in nature, composed of cells differing in size and shape – particularly ADSC 
where some cells were long and wavy whereas others were round or polygonal in shape.  
 
 The growth of DPSC, BMSC, ADSC and AMSC in culture was determined by counting the 
number of cells obtained after passaging on a weekly basis (Fig. 1E). Although DPSC 
exhibited the biggest cell loss after reviving from liquid nitrogen, they appeared to have the 
highest proliferative capacity of all cell types. BMSC had the lowest proliferative capacity 
meaning that less were available for experiments compared to the other cells. ADSC appeared 
to have a generally constant proliferative capacity but took longer to become established after 
reviving from liquid nitrogen, and AMSC, the only cell type not exposed to liquid nitrogen, 
appeared highly proliferative for only a short period of time. All MSC began to plateau with 
increasing passage number.  
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Figure 1. Morphology and Growth Characteristics of MSC in culture. The morphology of 
DPSC (A), BMSC (B), ADSC (C) and AMSC (D) at confluence is shown under standard culture 
conditions (x4 magnification). Cell number in culture was determined on a weekly basis when 
cells were passaged (E).  Because the cells were of various passage numbers, P0 represents the 
initial number the cells were frozen at (DPSC, BMSC and ADSC) rather than the actual cell 
passage number, except in the case of AMSC which were obtained by primary isolation.  Cells 
used for experiments were accounted for. 
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3.2 Ex Vivo Expansion Potential of MSC 
For cells to be used therapeutically or for large scale experiments, they must be readily 
expandable in order to obtain large numbers. The ex vivo expansion potential of MSC derived 
from dental pulp, adipose tissue and amnion was assessed by comparing those grown in 
standard media to those grown in EGF and bFGF after 7 days in culture (Fig. 2). Addition of 
both EGF and bFGF increased proliferation in all cell types, particularly DPSC and ADSC. In 
all cell types bFGF appeared to have a greater mitogenic effect than EGF.  
 
 
3.3 Multi-lineage Differentiation Potential 
MSC are renowned for their ability to differentiate into cells of a mesodermal linage, i.e. 
those of an osteogenic, adipogenic and chondrogenic phenotype. To compare the multi-
lineage differentiation potential of MSC, each cell type was grown in osteogenic and 
Figure 2. EGF and FGF increase MSC proliferation.  DPSC, ADSC and AMSC were cultured 
in standard media, EGF-supplemented media or FGF-supplemented media for 7 days and 
proliferation was determined (n=1, individual wells). D0= day 0 (seeding number), D7= day 7.  
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adipogenic media for 21 days. After only 7 days in culture BMSC, ADSC and AMSC showed 
morphological differences in both osteogenic and adipogenic treated groups compared to 
untreated groups, whereas DPSC in both osteogenic and adipogenic treated groups appeared 
the same as the untreated group (Fig. 3A). Vacuole formation, characteristic of adipogenic 
conversion, was visible in the cytoplasms of BMSC and particularly ADSC after 7 days and 
stellate, protruding cells characteristic of osteocytes were present in BMSC and ADSC. At 
this early stage, nodule formation was not observed in any of the groups.  
After 21 days cells were stained with Alizarin Red and visualised (Fig. 3B). Osteogenic 
conversion was observed in all cell types, indicated by the presence of calcification or 
‘nodules’ which absorb the dye. Nodules observed in DPSC and AMSC cultures appeared 
much larger than those in BMSC and ADSC. Mineralisation was semi-quantified by counting 
the number of Alizarin Red-positive nodules in four fields of view (Fig. 3C).  Results show 
that BMSC and AMSC stained positive for a significantly higher number of nodules than 
DPSC.  BMSC and AMSC also had more nodules than ADSC but this was not statistically 
significant. 
To investigate adipogenic conversion, MSC were cultured in adipogenic media for 21 days 
and were stained with Oil Red O (Fig. 3D). Unfortunately, technical issues prevented the stain 
from working and many of the cells lifted up, meaning that semi-quantification could not be 
achieved. However, evidence of adipogenic conversion, assessed by observing vacuole 
formation, was observed in BMSC and ADSC but not DPSC or AMSC. 
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Figure 3. Osteogenic and adipogenic potential of MSC. MSC were cultured in adipogenic and 
osteogenic media and analysed after 7 days in culture (A; x4 magnification). The osteogenic 
differentiation potential of MSC after 21 days was assessed by alizarin red staining (B). Osteogenic 
conversion was indicated by the presence of calcification or ‘nodules’ which take up the dye (x4 
and x10 magnification; shown by black arrows). Mineralisation was semi-quantified by counting 
the number of alizarin red positive nodules in four fields of view after 21 days culture in 
osteogenic media (C). Data are means ± SEM and were significant to * (P= <0.05) using a one-
way ANOVA with Tukey’s post-hoc test (n=2, triplicate wells except BMSC which were 
individual wells for each experiment). The ability of all four cell types to differentiate into 
adipocytes was determined by culture in adipogenic medium for 21 days (D). Cells were stained in 
Oil Red O but technical issues meant that the stain didn’t work properly and much of the cells 
lifted up, meaning that semi-quantification could not be achieved (x4 and x20 magnification).  
 
- 20 - 
 
3.4 Gene Expression and Growth Factor Secretion of MSC 
Gene expression of selected immunomodulatory (transforming growth factor-β1 (TGF-β1), 
interleukin-10 (IL-10) and cyclooxygenase-2 (COX-2)) and stem cell-related genes (octamer-
binding transcription factor-4 (oct-4) and nanog) was investigated under standard culture 
conditions by PCR (Fig. 4A & Fig. 4B). Gene expression was semi-quantified by normalising 
to the housekeeping gene, GAPDH, which was converted to 100% (not shown). Primer 
sequences are shown in table 1. TGF-β1 expression in DPSC was 19%, 2.3% in AMSC, 0.5% 
in BMSC and 0% in ADSC. COX-2 was highly expressed by DPSC (44.0%) and AMSC 
(34.0%), and also expressed by BMSC (8.7%) but not expressed by ADSC. Oct-4 was not 
expressed by DPSC but was expressed by BMSC (18.3%), ADSC (9.6%) and AMSC (9.2%). 
Nanog was highly expressed by BMSC (54.8%) and ADSC (51.3%) and was expressed to a 
lesser extent by AMSC (21.1%). Very low nanog expression was observed in DPSC (5.3%) in 
comparison to the other cell types. IL-10 was not expressed by any of the cell types.  
Cytokine secretion was analysed by ELISA after collecting supernatants from confluent MSC 
cultures. VEGF production (Fig. 4C) was highest in BMSC (3421 ± 112) and DPSC (2655 ± 
136) and lowest in ADSC (337 ± 152) and AMSC (228 ± 205). BDNF production (Fig. 4D) 
was highest in AMSC (184 ± 112) and much lower in BMSC (78 ± 37), DPSC (73 ± 8) and 
ADSC (53 ± 24). Secretion of both active and inactive forms of TGF-β1 (Fig. 4E) was highest 
in AMSC (17730 ± 5834), and again much lower in BMSC (8163 ± 1853), DPSC (8707 ± 
2023) and ADSC (5497 ± 2061). 
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Figure 4. Gene expression and cytokine secretion of DPSC, BMSC, ADSC and AMSC in 
standard culture conditions. An agarose gel showing amplified cDNA fragments produced by 
PCR (A). Gene expression of TGF-β1, COX-2, Oct-4 and nanog by MSC normalised against the 
housekeeping gene, GAPDH (B).  Results are displayed as a percentage of GAPDH expression 
(n=1). Confluent cell cultures were grown in complete media for 5 days and supernatants were 
collected and analysed for VEGF (C), BDNF (D) and TGF-β1 (E) secretion by ELISA. 
Experiments were repeated in duplicate from individual supernatants (mean ± standard 
deviation, n=1). Statistical analyses were not performed due to lack of repeated experiments.    
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3.5 The Effects of Ultrasound on MSC Proliferation 
Ultrasound has widely been reported to influence the function of a variety of cell types, but 
there has been no direct comparison of MSC from different sources thus far. The ultrasound 
machine was set up under sterile conditions applied to cells grown in six well plates (Fig. 5A) 
and following the application of ultrasound, some cells (AMSC, and ADSC on one occasion) 
had lifted up (Fig 5B; x4 magnification). 
 
 
 
Figure 5. The effects of ultrasound on MSC proliferation. The ultrasound machine was set up 
under sterile conditions with the transducer submerged in culture media supported by a metal 
clamp, and six well plates were supported by a custom-made silicone mould (A). Some cell 
types lifted up following ultrasound treatment (B). Cells were exposed to ultrasound for 1, 3 or 5 
minutes and proliferation determined after 96 hours (C). Data are means ± standard deviation 
(n=1) from duplicate wells (DPSC, ADSC and AMSC) or individual wells (BMSC). MSC were 
exposed to ultrasound for 5 minutes and proliferation determined after a 48 hour incubation 
period (D). Graph shows average number of cells per well from 3 pooled wells (n=1). 
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 The effect of various exposure times on the proliferation of MSC was investigated by 
determining proliferation after a 96 hour period (Fig. 5C). Cells were plated at a low enough 
density to enable proliferation, but high enough for the cells to remain viable. For the three 
time periods assessed (1, 3 and 5 min) results show that ultrasound had no significant effect 
on MSC proliferation or viability (assessed by trypan blue staining - data not shown).  
Using the 5 minute exposure time, the proliferation of MSC 48 hours after ultrasound 
exposure was also determined (Fig. 5D). Again, ultrasound appeared to have no significant 
effect on proliferation compared to the controls, although there was a slight reduction in cell 
number after ultrasound was applied to AMSC – possibly due to some of them lifting up.  
 
3.6 The Effects of Ultrasound on MSC Gene Expression and Cytokine Secretion 
Due to low cell numbers, only the gene expression of DPSC and ADSC were analysed. Gene 
expression was investigated 48 hours after a single 5 min ultrasound treatment (Fig. 6A & Fig 
6B). Primer sequences are shown in table 1.  
TGF-β1 expression in ADSC decreased by 20.6% (45.3-24.7%) but increased by 26.7% (7.4-
34.1%) in DPSC. COX-2 expression in ADSC was very low and decreased slightly after 
ultrasound treatment (3.2%), also decreasing in DPSC (21.2%).  Oct-4 expression increased in 
ADSC by 15.2% (14.8-30.0%) and decreased in DPSC by 9% (22.4-13.4%) and nanog 
expression increased in ADSC by 7.4% (9.8-17.2%) and decreased in DPSC by 4.9% (14.9-
10.0%). IL-10 expression was not expressed by any of the cell types.  
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Cytokine secretion was analysed by ELISA after collecting cell supernatants 48 hours after 
ultrasound treatment. Ultrasound appeared to increase VEGF production in DPSC and BMSC 
but decreased VEGF production in ADSC and AMSC (Fig. 6C). BDNF production (Fig. 6D) 
was generally low and showed no apparent trend, and TGF-β1 production (Fig. 6E) also 
appeared to show no trend.  
 
 
 
  
Table 1. PCR primer sequences, annealing temperature and product size (bp). GAPDH, 
gyceraldehyde 3-phosphate dehydrogenase; TGF-β1, transforming growth factor-β1; IL10, 
interleukin-10; COX-2, cyclooxygenase-2; Oct-4, octamer-binding transcription factor-4. Primers 
were designed using the Information Hyperlinked over Proteins (IHoP) website (http://www.ihop-
net.org/UniPub/iHOP) and the nucleotide-BLAST and primer-BLAST features of the National 
Centre for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/pubmed).  
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Figure 6. Gene expression of DPSC and ADSC and cytokine secretion of all MSC types 
after ultrasound treatment. An agarose gel showing amplified cDNA fragments produced by 
PCR (A). Gene expression of TGF-β1, COX-2, Oct-4 and nanog by DPSC and ADSC 
normalised against the housekeeping gene, GAPDH (B). Results are displayed as a percentage of 
GAPDH expression (n=1). Supernatants were collected 48 hours after ultrasound treatment and 
analysed for VEGF (C), BDNF (D) and TGF-β1 (E) secretion by ELISA. Experiments were 
repeated in duplicate from individual supernatants (mean ± standard deviation, n=1). Statistical 
analyses were not performed due to lack of repeated experiments.    
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Discussion 
4.1 Comparison of MSC from Different Sources 
 4.1.1 Morphology and Proliferative Capacity 
MSC reportedly display a fibroblast appearance in culture, which in this study was exhibited 
by all four MSC types analysed (Horwitz et al., 2005). DPSC and BMSC appeared long and 
spindle-like, whereas ADSC and AMSC appeared more stellate. This might reflect the origins 
of these cells and could suggest that DPSC and BMSC share a more similar developmental 
origin than ADSC and AMSC. The similarities between DPSC and BMSC have been 
confirmed by a previous analysis of over 4,000 human genes, which found that gene 
expression was remarkably similar between the two cell types (Shi et al., 2001). Therefore the 
large difference in proliferative capacity of DPSC and BMSC may be artefacts caused by 
external factors such as isolation protocol, length of time frozen, culture conditions and donor 
variability.  
Consistent with previous publications, BMSC displayed a lower proliferative capacity than 
MSC from other sources, indicating that ex vivo expansion is required or alternatively sourced 
MSC should be used (D’Ippolito et al., 1999; Kern et al., 2006). AMSC also displayed a 
comparatively low proliferation capacity; therefore it appears that donor variability such as 
age and developmental stage of the tissue plays a significant role in the proliferation of 
AMSC, and indeed other types of MSC. 
MSC are also characteristically heterogeneous in culture, which was displayed by BMSC, 
ADSC and AMSC but not DPSC – this phenomenon is unclear but could suggest that DPSC 
have been highly purified to the extent where only one cell type in this population exists, or 
that culture conditions have caused conversion to the predominating cell type. It is unlikely 
- 27 - 
 
that this morphological variation is a result of culture conditions as DPSC did not appear to 
change in morphology during their time in culture, and all four cell types were cultured in the 
same media. Conversely, DPSC may appear homogeneous morphologically but could be 
heterogeneous on a genetic level – a characteristic not revealed by appearance alone. Further 
work, including comparison of procured versus freshly isolated cells, would enable this 
phenomenon to be elucidated.    
 
4.1.2 Ex Vivo Expansion Potential of MSC  
The major limitation in this study is the generally low proliferative capacity of MSC. Many 
research groups supplement MSC culture media in order to enhance cell yield and viability. 
The findings in this study are in line with previous work that showed bFGF as a superior cell 
culture supplement to EGF, but with a side-by-side comparison of MSC from three different 
sources (Gharibi & Hughes 2012).  
An interesting observation was that during removal of adherent cells, those cultured in bFGF 
detached much quicker than cells in complete media or in EGF, to the extent that these cells 
were almost fully detached by the time the cells in the other groups had started to become 
loose. This suggests that bFGF may down-regulate the expression of adhesion molecules, 
supported by a recent report which demonstrated that bFGF significantly affects the 
expression levels of a range of adhesion molecules including the down-regulation of 
fibronectin and some integrins (Kashpur et al., 2013). 
Although addition of mitogens such as EGF and bFGF indeed increase MSC proliferation, 
effects on other aspects of MSC function should be carefully considered. There are certainly 
documented effects on gene expression and cell function during culture with mitogens 
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(Kashpur et al., 2013) but there may also be lasting effects continuing after their removal 
which could influence cell behaviour, ultimately impacting on the outcome of experiments, in 
vivo work or clinical trials. Therefore mitogens should only be used when necessary and 
selecting MSC types with a high proliferative capacity, such as DPSC, may abolish the need 
for mitogens. 
 
4.1.3 Differentiation Potential 
This study has shown that some MSC types are highly amenable to differentiation, exhibiting 
morphological alterations after only a few days in differentiation-inducing media. 
Specifically, BMSC, ADSC and AMSC displayed an altered morphology after only 7 days in 
both osteogenic and adipogenic media, and vacuole formation was observed in BMSC and 
ADSC after 7 and 21 days. Mineralisation was observed in all four cell types suggesting that 
all MSC are particularly amenable to osteogenic conversion. On semi-quantification 
mineralisation was greatest in BMSC and AMSC, however counting the number of nodules 
may not be entirely representative of osteogenic conversion as the size of nodules was not 
considered.  On closer inspection nodules in AMSC and DPSC cultures were much larger 
than in BMSC and ADSC cultures, so a more sensitive method of semi-quantification such as 
eluting and measuring the dye absorbed by each cell type or assessing alkaline phosphatase 
activity would better enable osteogenic conversion to be compared between MSC. A previous 
report has suggested that instead of the standard three week incubation period in 
differentiation media, nodule development is better seen after five weeks in culture; therefore 
it may not necessarily be that one MSC type is more plastic than another- it may just be that 
some MSC types are quicker at differentiating into other linages than others (Baksh et al., 
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2007). This could also apply to adipogenic conversion where it appeared that DPSC and 
AMSC did not exhibit vacuole formation.   
Interestingly, AMSC displayed very strong osteogenic conversion but no adipogenic 
conversion. This reluctance to convert to the adipogenic lineage has been widely reported, and 
adipogenic potential is thought to be displayed, albeit weakly, by very few donors (Wolbank 
et al., 2010, Lindenmair et al., 2012). This restricted differentiation potential has also been 
observed in umbilical cord-derived MSC which also fail to convert to the adipogenic lineage, 
whereas ADSC and BMSC could (Kern et al., 2006). 
Unsurprisingly, ADSC displayed stronger adipogenic conversion than other cell types and 
BMSC displayed stronger osteogenic conversion than all other cell types, suggesting that as 
with proliferative capacity, the differentiation potential of MSC strongly depends on their 
location in vivo. This is presumably a reflection of their developmental origin and suggests 
that MSC are site-specific and tailored to their location, with roles in repopulating specific 
cells (such as adipocytes for ADSC) within the stem cell niche.     
As donor age affects MSC plasticity, this variable, along with MSC source, should be 
considered where MSC are to be used in differentiation studies (D’Ippolito et al., 1999). 
 
 4.1.4 Gene Expression and Growth Factor Secretion 
Results from this study show that immunomodulatory genes (TGF-β1 and COX-2, an enzyme 
which generates prostaglandin E2; PGE2), were expressed the highest by DPSC and AMSC, 
with very little to no expression in BMSC and ADSC. However, TGF-β1 was highly secreted 
by AMSC in comparison to the other cell types, which exhibited similar, comparably low 
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secretion levels. This suggests that although DPSC express TGF-β1 there is downstream 
regulation modulating its secretion, also implying that large-scale secretion may be rapidly 
induced. These results correlate with a previous report suggesting that foetal-derived MSC 
secrete more TGF-β1 than adult-derived MSC (Deuse et al., 2011).  
COX-2 expression was highest in DPSC and then in AMSC, suggesting that these two cell 
types may be the most potent immunomodulators; however as previously discussed, increased 
gene expression does not necessarily mean that more protein is secreted– downsteam 
regulation could be occurring so these results must be carefully interpreted. IL-10 expression 
was not observed in any cell type, suggesting its expression is induced, for example by 
inflammatory stimuli. 
The pattern of VEGF secretion could be largely down to the role of different MSC in vivo. 
DPSC secrete VEGF to regulate dentine tissue repair and VEGF is important in BMSC-
mediated vascularisation, repair and cell signalling within the bone marrow, which could be 
responsible for their higher secretion (Mayer et al., 2005; Scheven et al., 2009). Alternatively, 
AMSC and ADSC may primarily secrete other growth factors to promote angiogenesis such 
as platelet-derived growth factor (PDGF) or interleukin-8 (IL-8) and indeed, TGF-β1 is also 
angiogenic, which is highly secreted by AMSC.   
A previous study showed that AMSC secrete more neurotrophic factors (such as BDNF), are 
more amenable to neuronal differentiation and express neural stemness markers compared to 
adult MSC which supports the finding that BDNF was highly secreted by AMSC in 
comparison to the other cell types (Yan et al., 2013). 
The genes for oct-4 and nanog, transcription factors associated with pluripotency and self-
renewal, were expressed highest by BMSC and ADSC, AMSC to a lesser extent and barely at 
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all by DPSC. Interestingly, this correlates with findings from the differentiation study, where 
BMSC and ADSC converted to both osteogenic and adipogenic lineages whereas AMSC, and 
to a lesser extent DPSC, only displayed osteogenic conversion. This suggests that BMSC and 
ADSC are more pluripotent than the other cell types and may be preferentially selected for 
differentiation studies; however this conflicts with a previous study which found that only 
foetal MSC express oct-4 and nanog (Guillot 2006). A later study also found that oct-4 was 
not expressed in adult MSC but that nanog was, and that nanog expression was not expressed 
in freshly isolated cells but took time in culture to become detectable, which may explain the 
apparently lower expression in AMSC (Pierantozzi et al., 2011). This group also found that 
nanog was only expressed in proliferating MSC; therefore nanog expression may have been 
influenced by other factors.  
 
4.2 The Effects of Ultrasound on MSC  
4.2.1 Viability and Proliferation 
In this study trypan blue staining indicated no apparent difference between control and 
ultrasound-treated groups, which is in agreement with previous reports (Zhang et al., 2003; 
Kang et al., 2011; Man et al., 2012). Conflicting data in the literature make it difficult to draw 
solid conclusions on the influence of ultrasound on cell proliferation, though it appears that 
short, single applications of ultrasound at the very least do not reduce proliferation. This is in 
agreement with the findings from this study that a single, 5 minute treatment does not 
influence MSC proliferation. Therefore, ultrasound appears not to be useful in affecting these 
parameters but may be applied to MSC cultures for other purposes with no adverse effects on 
proliferation and viability.  
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4.2.2 Cytokine Secretion and Gene Expression 
With the great variety in methods of ultrasound application and exposure times, it is difficult 
to directly compare the outcomes of previous ultrasound studies and data is sometimes 
conflicting. That gene expression in MSC is different in standard culture conditions compared 
to the control for the ultrasound study suggests that recent passaging and plating out 
influences gene expression compared to confluent, established cultures. Results from this 
study indicate that TGF-β1 expression was increased in DPSC but decreased in ADSC after 
ultrasound treatment, with secretion of active and inactive forms of TGF-β1 appearing to 
show the same phenomenon. In agreement with the literature, there was increased TGF-β1 
secretion by BMSC and AMSC. Though reduced TGF-β1 expression has not previously been 
described after ultrasound treatment, there has been a report of ultrasound having no 
significant influence on TGF-β1 expression, demonstrating variable findings in the literature 
(Al-Daghreer et al., 2012). Therefore, it would seem likely that its expression is not reduced 
after ultrasound treatment. 
Expression of stemness genes after ultrasound treatment also showed opposite trends in both 
ADSC and DPSC, increasing in ADSC but decreasing in DPSC after ultrasound treatment. 
This therefore suggests that ultrasound promotes self-renewal and pluripotency in ADSC, 
promoting stem cell-like properties, but causes DPSC to become less pluripotent. The effects 
of ultrasound on stemness gene expression has not been previously described, but it seems 
unlikely that ultrasound would have completely opposing effects in two similar cell types. 
This polar variation in gene expression could be due to contributions from external factors 
such as donor age or cell density (which may impact on the availability of nutrients), or a 
switch in gene expression to alternative but similar genes. Also, the values derived from this 
study are only relative as they are calculated based on GAPDH expression and compared to 
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‘resting’ control groups, so they may not be entirely representative of the true effects of 
ultrasound. 
Therapeutic ultrasound reportedly stimulates PGE2 production (Reher et al., 2002) but in this 
study, expression of the enzyme responsible for PGE2 synthesis, COX-2, decreased in both 
DPSC and ADSC after ultrasound treatment. It may be that COX-2 expression is initially 
upregulated to increase PGE2 synthesis before decreasing to compensate for the increased 
PGE2. Analysing gene expression at a single time point (48 hours) means that fluctuations in 
COX-2 expression are undetectable; therefore measuring total PGE2 secretion may be more 
indicative of the overall effect of ultrasound on COX-2 expression. 
Results show no apparent trend in BDNF secretion following treatment, though VEGF is 
increased in DPSC and BMSC, and decreased in ADSC and AMSC; however VEGF 
secretion was so low by ADSC and AMSC that this apparent decrease is likely insignificant. 
Also, because DPSC have a high proliferative capacity they quickly become confluent after 
plating out, whereas other cell types such as AMSC and BMSC struggled to become fully 
confluent, which may skew the results. Differences in VEGF secretion could be due to the 
location and function of the cells in vivo. For example, MSC in bone marrow niches are 
constantly subjected to mechanical forces associated with physiological activity (i.e. external 
forces) and the mechanical environment of the bone marrow (i.e. internal forces) acting upon 
the bone marrow microenvironment (Gurkan et al., 2008). As such, external stressors such as 
ultrasound that influence biochemical pathways may be processed differently by MSC 
depending upon their location and function.  
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4.3 Assay Refinements and Future Work 
4.3.1 Cell Source and Procurement  
In this study, MSC were either purchased from commercial companies which involved 
pooling and freezing (DPSC, BMSC and ADSC) or were isolated from single donors with no 
freezing (AMSC), meaning that the cells were not directly comparable. Using freshly isolated 
cells from a known source is more reliable so if possible, future studies should use freshly 
isolated MSC. 
 
4.3.2 Improving the Reliability of the Findings 
Much of the data presented in this report is not technically reliable due to the lack of 
replicates within individual experiments and lack of repeated experiments, meaning that 
statistical analyses could not always be applied. The major limitations were cell number, 
hence why the ex vivo expansion potential of the cells was investigated, and lack of time. 
Repeating the experiments would provide a better indication of the true biology occurring.  
 
4.3.3 The Influence of Culture Conditions on MSC Function 
The addition of mitogens or other supplements such as vitamins to standard growth culture 
medium is controversial, but their effects on MSC proliferation are well documented. If MSC 
are expanded using mitogens with the intention of being used for a cellular therapy then the 
long term effects must be properly validated, hence rigorous testing must take place. As both 
EGF and bFGF were used at 10ng/ml in this study, the effects of higher or lower 
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concentrations of both growth factors is unclear. Growth factor titration may provide more 
information, and assessing proliferation by an alternative method rather than cell counting 
may be more appropriate for this purpose. For example, a colourimetric assay such as MTT, 
XTT or WST-1 which takes a 96 well plate format would enable high throughput analysis of 
viable cells and is often available as a ready-to-use kit. 
 
4.3.4 Expanding the Ultrasound Study 
Though therapeutic ultrasound has been used since the 1940’s, the application of ultrasound 
to influence cell function in vitro is relatively recent and though many publications report that 
ultrasound can affect cell behaviour and function, its precise biochemical mechanisms are 
generally still elusive (Paliwal & Mitragotri 2008). The wide variations in intensity and 
frequency make it difficult to collate and translate experimental data, and many studies use 
limited combinations (if at all) of intensity and frequency to deliver ultrasound to cells, often 
leading to repetition of results. Also, the ultrasound exposure time and culture period of cells 
post-treatment is variable and is likely to show variations in gene expression depending on 
when the cells are harvested, providing massive scope for future work. Ideally, a publicly 
accessible database or review document containing results from previous ultrasound studies 
would be available to enable researchers to efficiently progress in this field. Future studies 
should look at the effects of a wider range of ultrasound treatments on cell behaviour, 
factoring in different exposure times and analysis times of cells post-treatment.  
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4.3.5 Direct Analysis of Immunosuppressive Properties 
Analysing gene expression or cytokine secretion as markers of immunosuppressive capacity is 
a biased approach as immunosuppression is a complex process mediated by a host of soluble 
and cell-bound factors and as such, upregulation of one particular immunosuppression-related 
gene does not necessarily relate to more potent immunosuppression. Assessing 
immunosuppressive capacity by proliferation assay, which measures the ability of MSC to 
inhibit peripheral blood mononuclear cell (PBMC) proliferation, may provide a more 
representative indicator of immunosuppression.  
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Conclusions 
Sourcing of MSC has important implications for the function and availability of cells for 
research and therapeutic purposes. Because BMSC exhibit a low proliferative capacity they 
may not be the cell of choice if other MSC are available, however the addition of media 
supplements such as bFGF or EGF may improve cell yield for large-scale experiments or cell 
therapies.  
The data in this report provides a snapshot of gene expression and cytokine secretion of MSC 
which in vitro may be influenced by cell culture conditions, and in vivo may be influenced by 
external factors such as mechanical stressors. On the whole, AMSC expressed reasonable 
levels of both immunomodulatory and stemness genes analysed, suggesting they are versatile 
and ideal for all-round purposes. Though it is unclear from this study whether AMSC possess 
enhanced properties over adult MSC, birth-associated tissues are an excellent source of MSC 
due to their simple retrieval and plentiful supply. DPSC have a very high proliferative 
capacity and may also be better applied for immunomodulatory purposes, however 
immunomodulation is a complex and multi-factorial process influenced by many factors and 
is difficult to summarise by analysing such few cytokines. Expression of ‘stemness’ genes 
appeared to reflect the differentiation potential of MSC and suggested that BMSC and ADSC 
may be better used for differentiation studies for example across linage boundaries, such as in 
conversion to insulin-secreting cells for a cell-based diabetes therapy. Therefore, researchers 
could select the type of MSC based on their requirements.  
Ultrasound is a promising avenue of research with great potential not only for enhancing cells 
in vitro and for cell based therapeutics, but also as a therapy in itself by direct application to 
damaged tissues. Ultrasound may or may not influence gene expression and cytokine 
- 38 - 
 
secretion in different cell types as it is difficult to confidently evaluate this based on the 
current literature. Therefore much work is required to evaluate the effects of different 
intensities, frequencies, exposure times and long-term effects on cell cultures for ultrasound to 
be reproducibly and effectively applied in the future.  
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